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Abstract 
 
The role of the Peripheral Nervous System on the regulation of bone re modelling is 
widely accepted, mainly through Y1 Receptor (Y1R) signalling. Y1R knockout (KO) mice 
demonstrated an increase in Osteoblast (OB) driven bone formation and Osteoclast (OC) 
surface and therefore demonstrate a great therapeutic potential in the treatment of bone 
degenerative diseases. However, the effect of Y1R in osteoclastogenesis is unknown. 
Therefore, the main objective of this work is to study the role of Y1R in OC 
differentiation and bone resorption. In order to achieve this goal, Y1R KO animal model was 
used to ascertain the influence of Y1R in OC behaviour. In addition, OC Y1R blockage with the 
specific antagonist BIBP3226 was used to determine if the Y1R pathway was responsible for the 
observed results in Y1R KO OCs. Furthermore, the involvement of Y1R in OB/OC crosstalk was 
studied using an OB/OC direct co-culture. 
The absence of Y1R signalling led to increased osteoclastogenesis, with increased TRAP
+ 
Multinucleated Cells (MNC) formation and OC section area, together with an increase in 
Macrophage Chemotactic protein 1 (MCP1) expression. However, Y1R KO OC exhibited 
impaired resorption activity, with decreased TRAP and Cathepsin K (CATK) expression. In 
addition, BIBP3226 treatment of WT OCs led to increased osteoclastogenesis with higher 
number of TRAP+ MNCs, but no significant differences in OC section area. However, similarly to 
Y1R KO cells, OC resorption capacity was impaired, with reduced resorption pit volume and 
area. 
OB derived from Y1R KO mice revealed a significant increase of Receptor activator of 
nuclear factor-κβ ligand (RANKL) expression, which was associated with an increased 
expression of OC differentiation markers in a direct OB/OC co-culture. However, no differences 
were observed in TRAP+ MNC numbers. Mineralization staining and quantification did not led 
to any definite conclusion, with no statistically significant differences being observed. 
BIBP3226 treatment of the OB/OC co-culture also revealed increased OC differentiation 
markers and no significant differences in osteoclastogenesis and calcium depositi on. 
Taken together, these results helped decipher the role of Y1R signalling in OC behaviour 
while studying the effect of BIBP3226 treatment. Furthermore, the influence of Y1R in OB/OC 
crosstalk was explored. 
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Chapter 1 – An Introduction to Bone Biology 
 
Bone Functions, structure and composition 
 
Although usually regarded as a static and inert material, bone is a highly dynamic living 
tissue. It is constituted by inorganic and organic components which together with various 
types of cells carry out several important functions in the human body. 
The Skeletal System is responsible as the support of body architecture, as the softer 
tissues and organs are attached to the skeleton. It ensures the protection of internal organs 
from external damage as well, protecting the heart, lungs and brain for instance. Other 
functions include locomotion, as the bones interact with skeletal muscles allowing movement, 
and also mineral homeostasis and energy storage. Finally, bone also provides a cavity for 
hematopoiesis, the production of blood cells and platelets [1].  
There are two morphologically different forms of bone: cortical (compact) bone and 
cancellous (spongy) bone. Cortical bone is formed by densely packed collagen fibrils organized 
in concentric lamellae and they constitute around 80% of the skeleton, being found in the 
diaphysis of long bones (Figure 1) [2] and also in the outer surface of flat bones such as the skull. 
On the other hand, cancellous bone is composed of a loose and porous matrix established by  
beam-like structures, the trabeculae, and is found mostly in the epiphysis of long bones and 
the inner part of flat bones[3]. The periosteum is a fibrous structure that envelops the outer 
surface of the bone through Sharpey’s fibers and contains blood vessels to ensure nutrient 
supply, nerve endings and bone cells such as osteoblasts (OB) and osteoclasts (OC). The inner 
surface in contact with the bone marrow is covered by a membrane, the endosteum, where 
there are also blood capillaries, OBs and OCs[4]. 
Most of the bone is composed of extracellular matrix (ECM), which has several 
components including a mineral phase, collagenous and non-collagenous proteins, lipids and 
water. The major constituents of the mineral phase of the ECM are calcium, magnesium and 
phosphate, forming crystals of hydroxyapatite deposited in the collagenous matrix of the 
bone. These minerals provide a high mechanical resistance to the tissue and also serve as a ion 
source for mineral homeostasis[5]. Type I collagen, a triple-helical protein characterized by a 
Gly-X-Y repeating triplet (X and Y are usually Proline and Hydroxyproline, respectively) , is the 
basic building block of the bone matrix and serves as a scaffold for the binding and orientation 
Figure 1 – Long bone structure. Compact bone is formed by densely packed collagen fibrils 
organized in concentric lamellae, located mainly in the diaphysis of the long bone. Spongy bone is 
composed of a loose and porous matrix established by trabeculae and is found in the epiphysis. The 
bone is highly vascularized and enveloped by a fibrous structure in the outer surface, the periosteum, 
and a membrane in contact with the bone marrow, the endosteum. Adapted from 
[2]
. 
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of other proteins that promote the hydroxyapatite deposition. Besides collagen, other proteins 
such as proteoglycans, glycosylated proteins and serum-derived proteins play a fundamental 
role in the matrix organization and mineralization as well as in the modulation of bone cell 
attachment and activity. Finally, approximately 10% of the bone weight is attributed to water, 
which is important for cell nutrition, ion flux control and collagen structure maintenance [6]. 
 
Bone Cells 
 
OBs, OCs and Osteocytes are the main types of cells present in the bone and they are 
originated from different sources [7]. These cells communicate with each other in a tightly 
controlled manner either by direct contact or through signalling molecules in order to perform 
several key physiological processes such as bone growth and remodelling. 
 
Osteoblasts 
 
OBs are the cells responsible for bone formation. They are derived from Mesenchymal 
Stem Cells (MSC) present in the bone marrow, which are also capable of differentiating into 
chondrocytes and adipocytes[8]. 
OB differentiation is highly regulated and can be divided in four stages: lineage 
commitment, proliferation, matrix maturation and mineralization stage [9]. This process is 
summarized in Figure 2. MSC commit to the OB lineage through the influence of Bone 
Morphogenetic Protein (BMP) and differentiate into Osteoprogenitor cells in the first stage. 
Figure 2 - Differentiation of MSC into mature OBs. MSC differentiate into osteoprogenitor cells by 
the influence of BMP2, which then differentiates into Pre-OBs through PTH signalling. Finally, IGF-1 and 
PGE2 cause the differentiation into mature OBs, which can then become into osteocytes or bone lining 
cells. Adapted from
[11]
. 
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These cells have a high rate of proliferation and express Runt-related transcription factor 2 
(Runx2), a transcription factor of great importance that suppresses MSC differentiation into 
chondrocytes and adipocytes. Runx2 regulatory element is present in the promoter of several 
OB genes controlling their expression, including type I collagen, alkaline phosphatase (ALP), 
bone sialoprotein (BSP) and osteocalcin leading to an OB phenotype [10]. Another important 
transcription factor is Osterix (Osx), a zinc-finger transcription factor that acts downstream of 
Runx2 and modulates OB differentiation, bone formation and mineralization[11]. 
Osteoprogenitor cells differentiate further into pre-OBs under the influence of the 
Parathyroid hormone (PTH). PTH induces the expression of ALP, collagen type I and BSP-II, 
involved in the production of bone matrix components[12]. In addition, PTH stimulates the 
receptor activator of nuclear factor(NF)-κβ (RANK) ligand (RANKL) mRNA expression, which 
performs a central role in OC maturation, as well as other matrix components and growth 
factors[13]. Parallel to PTH signalling, the Wnt/β-catenin signalling pathway also acts on the 
promotion of osteoblast differentiation, proliferation and matrix mineralization. Briefly, Wnt 
proteins, a group of secreted cysteine-rich glycoproteins, bind to a complex of receptors 
composed of Frizzled receptor and Low-density lipoprotein Receptor-related Protein 5 and 6 
(LRP5/6) at the cell surface and inhibit glycogen synthase kinase 3β (GSK-3β) which was 
phosphorylating β-catenin for proteossomal degradation. Thus, β-catenin accumulates in the 
nucleus and causes target gene expression [14]. The importance of this pathway was 
demonstrated in gain-of-function studies where mice overexpressing LRP5 in OBs had 
increased bone volume and strength[15]. 
Subsequently, pre-OB differentiate into mature OBs through the combined action of 
Insulin growth factor 1 (IGF-1) and Prostaglandin E2 (PGE2) leading to the expression of 
specific markers such as osteocalcin, collagenases, BSPI, BSPII and ALP, characteristic of the 
matrix mineralization stage. Mature OBs are cuboidal cells which show typical secretory 
characteristics, with a well-developed rough endoplasmic reticulum and a large Golgi 
apparatus necessary to the production of bone matrix components [16].  
Lastly, OBs may have three possible cellular fates: undergo apoptosis, become quiescent 
bone lining cells or become osteocytes. Osteocytes are OBs that became entrapped during 
bone deposition. They represent around 90% of the cells within the bone matrix and are 
characterized by a star-shape morphology with dendritic extensions that form a canalicular 
network, thus allowing the osteocyte network response to changes in mechanical and 
chemical stimulus from the bone microenvironment and systemic messages from the blood 
stream[17]. Aditionally, osteocytes are involved in the adaption of the bone to mechanical 
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forces and the regulation of OB and OC functions in the bone remodelling process. One of the 
most described proteins expressed by osteocytes is sclerostin, a protein that acts on OBs 
through LRP5 binding and interferes with the Wnt/β-catenin signalling cascade, leading to 
bone formation inhibition[18]. Bone lining cells, on the other hand, are important in bone 
remodelling regulation through the expression of several factors such as RANKL and for the 
formation of a closed canopy that keeps the cellular precursors localized and in contact with 
an adequate concentration of the factors released from the bone remodelling site [7]. 
Besides being responsible for bone formation, OBs have a preponderant role in OC 
regulation. 
 
Osteoclasts 
 
OCs are multinucleated cells responsible for bone resorption derived from cells of the 
hematopoietic myeloid lineage, as depicted in Figure 3. Myeloid progenitors differentiate into 
OC precursors (OCP) under the influence of factors such as PU.1 and microphtalamia -
associated transcription factor (MITF), which induce the expression of Macrophage -colony 
stimulating factor (M-CSF) receptor (M-CSFR). M-CSF is secreted by OBs and upon priming with 
its receptor promotes the survival, proliferation and differentiation of OCPs by activation of 
extracellular signalling-regulated kinase (ERK) 1/2 and phosphatidylinositol 3-kinase (PI3K)/Akt 
signalling pathways[19]. Additionally, M-CSF leads to the expression of RANK, a Tumour Necrosis 
Factor (TNF) receptor (TNFR) related protein which is a key player in osteoclastogenesis and 
regulation of OC activity[20]. 
Activation of RANK by its ligand, RANKL, leads to the expression of OC specific genes 
during differentiation such as Cathepsin K (CATK), Tartrate-Resistant Acid Phosphatase (TRAP), 
Figure 3 – Osteoclastogenesis. Bone marrow precursors differentiate into Pre-OC under the 
influence of M-CSF. Pre-OC express RANK which when bound to RANKL promotes proliferation, 
differentiation and Pre-OC fusion leading to the formation of multinucleated cells expressing 
characteristic OC markers such as TRAP and CTR. RANKL also modulates OC activity leading to active 
bone resorption. OPG acts as a soluble decoy of RANKL, inhibiting OC differentiation. Adapted from 
[20]
. 
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Figure 4 – Ilustration of OC Morphology. During 
maturation, OC membrane is restructured, forming a sealing 
zone to isolate the bone surface to be resorbed. In the apical 
membrane in contact with the bone, membrane extensions are 
projected forming a ruffled border which releases protons and 
enzymes causing the acidification and degradation of the bone 
surface. Organelles are situated in the basolateral side of the 
cell: RER-Rough Endoplasmatic Reticulum; N-Nuclei; G-Golgi 
Stack; M-Mitochondria; L-Lysosome. Adapted from 
[28]
. 
αvβ3 integrin and Calcitonin Receptor (CTR) and promotes further survival and activation of OC 
resorptive activity[21]. Trimerization of both RANK and RANKL is required for the activation of 
subsequent signalling cascades[7].  Considering that RANK lacks intrinsic enzymatic activity in its 
intracellular domain, signal transduction is accomplished by the recruitment of adaptor 
proteins such as the TNFR-associated cytoplasmic factor (TRAF) family of proteins. Specifically, 
TRAF6 is involved in the phosphorylation of  the Inhibitor of NF-κβ kinase (IKK), c-Jun N-
Terminal kinase (JNK) and Src, resulting in the activation of NF-κβ, Activator protein 1 (AP-1) 
and nuclear factor of activated T cells(NFAT)-2 which are then directed to the nucleus and 
promote the expression of OC specific genes and signalling for the survival, differentiation, 
motility and cytoskeleton rearrangement[20-22].  
At this stage, proteins like Dendritic-cell specific transmembrane protein (DC-STAMP), 
CD9 and the d2 isoform of the vacuolar ATPase (v-ATPase) V0 domain (Atp6v0d2) begin to 
express and are crucial in Pre-OC cell fusion, the next step in Osteoclastogenesis[23]. CD9 is a 
membrane glycoprotein expressed under RANKL stimulation in lipid rafts that enhances Pre-OC 
fusion into multinucleated mature OC[24]. Similarly, DC-STAMP expression is stimulated by 
RANKL and its involvement in Pre-OC fusion was demonstrated through inhibition studies 
where DC-STAMP-/- mice showed a defect in Pre-OC fusion[25].Lastly, inactivation of Atp6v0d2 
generates deficient osteoclasts without affecting the v-ATPase activity, being considered a 
regulator of Pre-OC fusion and bone formation[26].  
OBs can further modulate OC activity through the secretion of Osteoprotegerin (OPG) . 
OPG is a soluble TNFR-like protein that behaves as a soluble decoy of RANKL, thus inhibiting its 
activity and impairing OC differentiation [27, 28]. 
After Pre-OC fusion, mature OCs present a distinctive morphology, as represented in 
Figure 4. Its membrane forms an outer ring which isolates the bone surface to be resorbed, the 
“sealing  zone”, and the apical membrane presents irregularly shaped membrane extensions 
similar to microvilli, the “ruffled border”[29]. Mature OCs are responsible for actively resorbing 
bone surfaces and they do so by 
expressing several proteins 
important for the demineralization 
and degradation of the bone matrix: 
v-ATPase along with 2Cl -/H+ 
antiporter are responsible for the 
acidification of the resorption area 
necessary for the demineralization 
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of the bone surface; the acidic hydrolase CATK and also Matrix Metalloproteinases (MMP) such 
as MMP2 and MMP9 degrade the exposed Collagen type I network[29]; TRAP is a highly 
expressed acidic hydrolase that is crucial for bone resorption as demonstrate d through 
experiments with TRAP-/- mice that showed an impairment in the bone resorption process [30], 
but the underlying molecular mechanisms are still poorly understood.  
These key features in OC physiology and activity are tightly regulated by OBs and other 
cells and systemic factors, coupling bone formation and resorption during all stages of 
development, namely during bone growth and bone remodelling.  
 
Bone development, growth and remodelling 
 
In the human foetus, bones are derived from three embryonic mesenchyme structures: 
the somites, which generate the axial skeleton; the lateral plate, which generates the limb 
skeleton; and the neural crests, which generate the skull and facial bones [31]. Bone formation 
occurs either by a direct conversion of the mesenchyme into bone tissue, the 
intramembranous ossification characteristic of the flat bones, or an indirect process where 
previously formed rudimental cartilage is replaced by bone tissue, the endochondral 
ossification, typical in the development of most of the bones including the long bones [3]. 
In both processes, the primary bone formed is a random arrangement of collagen type I 
fibers and no mechanical competence, also termed as osteoid, which is then replaced by a 
secondary bone with a highly organized collagen structure in concentric lamellae. Primary 
bone is produced rapidly and appears in the fourth month of foetal life, while the replacement 
with secondary bone starts before birth [31]. 
In intramembranous ossification, MSCs previously condensated in compact nodules 
expand outwards and differentiate into capillaries and cells from the OB lineage, defining the 
early shape of the developing bone. Following osteoid component secretion and early 
mineralization of bone spicules by OBs, these structures fuse together in a trabecular structure 
forming primary bone [32]. Contrarily, endochondral ossification involves the early formation of 
a cartilage model by chondroblasts derived from MSCs. A primary ossification center appears 
in the cartilage rudiments and starts forming the diaphysis of long bones, followed by the 
development of secondary ossification centers and cartilaginous growth plates in the 
epiphyseal ends. These are later replaced by primary bone and thus leading to bone growth[33]. 
Healthy skeletal growth is achieved through a bone modelling process characterized by a 
change in bone shape through an unbalanced mechanism favouring bone formation instead of 
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bone resorption leading to growth and mechanical adaptation. This starts in the late foetal 
stage of development and ends at about 18 to 25 years of age and its highly regulated through 
the effects of systemic factors, mainly PTH in childhood and sex hormones during puberty [31]. 
Once the human skeleton has matured, the maintenance of bone homeostasis is 
fundamental and it is mainly achieved through a Bone Remodelling process which main roles 
are the regulation of the mass, mechanical integrity and mineral composition of the bone [17]. In 
this process are involved various cell types such as OB, OC, Osteocytes and Bone Lining cells 
organized in basic multicellular units (BMU) throughout the bone’s surface , as depicted in 
Figure 5. These BMU provide a sealed microenvironment where there can be a close 
interaction between the involved cells[7]. The BMU present in cortical and trabecular bone are 
distinct in their structures and bone remodelling mechanisms. In trabecular bone, BMUs are 
located on the surface of the bone and are covered by a canopy of lining cells with OB filling 
the previously OC resorbed space. On the other hand, BMU in the cortical bone are comprised 
of a cutting zone where OC proceed through the bone followed by bone forming OB. Bone 
remodelling takes place throughout the skeleton at BMUs in an independent and non -
synchronous way[34]. 
Bone remodelling in each BMU is composed of four phases: activation of the target bone 
surface, recruitment of OC to perform bone resorption, transition from resorption to bone 
formation and finally recruitment of OB to form new bone [35]. The signal for the initiation of 
Figure 5 - The organization of a BMU. OBs and OCs are responsible for bone formation and 
resorption, respectively, and are formed from precursors supplied by the bone marrow or bloodstream. 
BMUs differ in their structure and organization depending on whether they are located on cortical or 
trabecular bone. Adapted from 
[30]
. 
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bone remodelling might be presented either by osteocyte secretion of sclerostin and other 
factors that stimulate osteoclastogenesis[17] or even by the apoptosis of some osteocytes and 
bone lining cells of the canopy in the BMU that release chemokines and paracrine factors, such 
as Sphingosine-1-phosphate (S1P) that recruit hematopoietic OCs precursors from the 
surrounding blood vessels and from the nearby bone marrow [36]. 
After Pre-OCs recruiting, M-CSF and RANKL secreted by cells from the OBs lineage come 
into play in the OC differentiation and multinucleated OCs start bone resorption. 1,25- 
dihydroxyvitamin-D3 (VitD3) is a hormone that stimulates osteoclastogenesis through its 
induction of RANKL secretion by OBs, being very important on bone remodelling induction, 
although there are reports of an administration of VitD3 being responsible for an increase in 
bone density in osteoporotic patients. This seemingly paradoxical interaction may be explained 
by different pharmacological and physiological effects of VitD3, which is involved also in 
intestinal absorption of calcium and thus explaining a decrease in osteoclastogenesis and 
increase in bone formation[37]. 
Soon after OC maturation, a combination of acid hydrolases like CATK and TRAP along 
with an acidification of the resorption site through the transport of H+ by v-ATPases and 2Cl-
/1H+ antiporter causes the demineralization of the bone and the exposure and degradation of 
its organic components[29]. This process also causes the release of factors such as Transforming 
Growth Factor-β (TGF-β) and IGF-1 from the degraded matrix regulating OCs function, and 
these are linked to the coupling between bone resorption and bone formation by activating 
nearby OBs precursors. Other chemoattractant factors that recruit OBs precursors to the 
resorption site include Platelet-Derived Growth Factor-BB (PDGF-BB) and also S1P[35]. 
The transition between bone resorption and formation is very important and a balanced 
remodelling requires the formation of the same amount of resorbed bone. Calcitonin, a 
thyroidal hormone, inhibits OC activity by loss of the “ruffled border” and changes in the actin 
cytoskeleton and cell adhesion[38]. Similarly, OB produced OPG hinders osteoclastogenesis by 
sequestering RANKL and thus allowing the coupling from bone resorption to bone formation. 
At the same time, direct contact between OB and OC further stimulates OB differentiation and 
survival through the OC membrane protein EphrinB2 that binds to the membrane receptor 
with tyrosine kinase activity EphB4 present on the surface of OB precursors that activates 
ERK1/2 signalling pathways[34]. 
Finally, differentiated OBs adhere to bone surfaces and start to secrete an organic 
matrix composed of collagen type I, the osteoid, which is then mineralized through the 
deposition of hydroxyapatite crystals induced by alkaline phosphatase (ALP) expressed by OBs. 
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Chapter 2 – Neuropeptide Y and Bone 
 
It is evident that intercellular communication plays a fundamental role in bone 
remodelling. However, this is not exclusive for bone cell - bone cell signalling but instead the 
nervous system is also responsible for the regulation of bone remodelling. Sympathetic and 
sensory nerve fibres are present throughout the bone marrow, mineralised bone and 
periosteum and although there is no proof of the establishment of synapses between ne rve 
fibers and bone cells, the effect of several neuropeptides in close association with these cells is 
apparent[39]. 
Substance P (SP), Calcitonin gene-related protein (CGRP), Vasoactive Intestinal Peptide 
(VIP), Serotonin and Neuropeptide Y (NPY) are some of the neuropeptides studied that have a 
regulatory function in bone remodelling and homeostasis. SP is a well-known nociceptive 
molecule that is typically associated to sensory nerves and has been shown to promote BMU 
formation and OBs differentiation and cAMP production. At least one of its receptors, 
neurokinin-1, is also present in OCs and it drives OCs resorption activity [40]. CGRP has a similar 
effect on OBs, promoting the increase of intracellular cAMP and calcium which leads to 
changes in morphology and function. Thus, CGRP induces OBs proliferation, collagen synthesis 
and bone formation and besides being secreted by neuronal terminals it can also function as 
an autocrine mediator, because it can be also produced by OBs [41]. VIP is a neuropeptide 
associated to para-sympathetic nerves and it has an important role in controlling 
osteoclastogenesis by inhibiting RANK expression and increasing the expression of OPG in OBs, 
decreasing the resorption activity of OCs [40]. Serotonin is a peptide that modulates mood, 
emotion, sleep and appetite but it is also involved in bone regulation, namely on OBs and OCs 
differentiation and transduction of mechanical stimulus from osteocytes [41]. NPY function and 
importance are demonstrated below. 
 
NPY system 
 
NPY is a 36 amino-acid peptide with a highly conserved primary structure that was 
isolated for the first time from porcine brain and since then has been found in  all mammals 
and in a wide range of animal species[42]. NPY, in conjunction with the intestinal peptide YY 
 
     10 
 
(PYY) and the pancreatic polypeptide (PP), form the NPY-family of proteins. In addition, these 
proteins are characterized by having a common tertiary structure, the PP-fold, with an N-
terminal polyproline sequence and an amphiphilic α-helix joined together by type I β-turn 
creating a hairpin loop, having a critical importance in the interaction with its receptors[43]. 
NPY is highly abundant in the mammalian brain and is distributed throughout the central 
nervous system (CNS) particularly in the hypothalamus, cerebral cortex, brain stem, striatum 
and limbic structures. In the periphery, NPY is found in the sympathetic nervous system co-
stored and released with noradrenaline during nerve stimulation [44]. Thus, due to this 
widespread expression, NPY plays an important role in a large range of biological processes 
such as feeding behaviour, learning and memory, body temperature regulation, emotional 
behaviour, circadian rythms, pain, sexual behaviour and hormone secretion. Furthermore, NPY 
seems to be implicated in several disorders such as obesity, epilepsy, depression and bone 
formation disorders[43]. Interestingly, NPY is being identified in peripheral tissues, where both  
OBs and adipocytes are able to produce NPY[44]. 
Overall, a pivotal role of a hypothalamic central pathway in bone homeostasis has been 
widely accepted due to in vivo evidence, especially from experiments where leptin defi cient 
mice demonstrated an increased cancellous bone volume, and this effect is abrogated by the 
local administration of leptin in the hypothalamus [45, 46]. Leptin is a small polypeptide secreted 
by adipocytes that is primarily involved in the control of body weight and gonadal function and 
exerts its effects on the hypothalamus. The leptin-dependent bone formation inhibition seems 
to be independent from the NPY pathway, because the leptin-deficient stimulation of bone 
formation is maintained in the presence of high hypothalamic concentration of NPY [47].  
The NPY system is the other major component of the neural output from the 
hypothalamus to bone. In humans, NPY can signal through four G-Protein Coupled Receptor 
(GPCR) subtypes, Y1, Y2, Y4 and Y5 expressed widely in central and peripheral tissues
[48]. Their 
location and functions are explicit in Table I [49].       
Particularly, Y1 receptor (Y1R) and Y2 receptor (Y2R) have been demonstrated to have an 
important role in bone growth and remodelling, which was further evidenced by the presence 
of NPY reactive nerve fibres on bone and surrounding tissues and by proof of expression of 
NPY by OBs[50]. These are activated by ligand binding and upon persistent agonist stimulation, 
the receptors are specifically phosphorylated at Ser/Thr residues which cause s the uncoupling 
of the receptor from the G protein and consequent desensitization [49]. This is considered a 
crucial physiological process to avoid further G-protein signalling and maintain cellular 
homeostasis. The specific phosphorylation subsequently leads to arrestin protein binding and 
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clathrin-dependent internalization into endosomes. Once internalized, the receptor is 
dephosphorylated and can be recycled back to the cellular membrane or can be targeted for 
proteosomal degradation[51]. 
Table I – Y Receptor subtypes and their distribution and function 
 
Baldock and his team were the first to observe a two-fold increase in the trabecular 
bone density in Y2R germline knockout (KO) mice due to a higher OB activity without significant 
changes in OB and OC surface and have shown that a selective deletion of hypothalamic Y2R 
yielded a similar result, suggesting that Y2R signalling acts on bone homeostasis through a 
central pathway. The lack of changes in the levels of leptin and pituitary hormones in the 
plasma point to a Y2R modulation of bone formation by neural mechanisms and not by an 
indirect increase or decrease in blood circulating hormones [52]. Besides inherent changes in 
cellular metabolism, elevated bone mineralization and formation rate in Y2R KO mice might be 
due to an increased number of Osteoprogenitor cells in the bone , as Lundberg and co-workers 
demonstrated[53], although the colony-forming ability of these cells is unchanged when 
Receptor Location Function 
Y1 
Brain 
Vascular smooth muscle cells 
Adipose tissue 
Kidney 
GI tract 
Bone tissue 
Energy homeostasis 
Neuroendocrine regulation 
Bone homeostasis 
Ethanol consumption 
Seizure regulation 
Anxiety regulation 
Angiogenesis 
Y2 
Neuronal tissue 
Spleen 
Liver 
Blood vessels 
Adipose tissue 
Bone Homeostasis 
Anxiety regulation 
Cardiovascular regulation 
Energy homeostasis 
Y4 
GI tract 
Hippocampus 
Cardiovascular regulation 
Energy homeostasis 
Y5 
Hypothalamus 
Thalamus 
Amygdala 
Cerebral cortex 
Energy homeostasis 
Seizure regulation 
Angiogenesis 
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compared to a wild-type phenotype. Furthermore, Y2R seems to be involved in the 
proliferation and differentiation of the OB lineage since treatment with NPY increased the 
expression of OB specific markers such as ALP and osteocalcin, a result that was maintained 
when the cells were treated with a Y2R agonist and abrogated upon treatment with a specific 
antagonist[54]. However, treatment with NPY decreased the mineral deposition in spite of the 
increase in OB markers expression, which is consistent with the increase in bone formation in 
Y2R KO mice but it is a process not yet fully understood
[54]. 
Interestingly, Y1R expression was significantly down-regulated in Y2R KO mice probably 
due to the lack of feedback inhibition of NPY release leading to an over stimulation and 
consequent desensitization and down-regulation of Y1R in the bone cells, which may be 
involved in the increase in bone formation and mineralization phenotype observed in these 
mice[53]. 
 
Role of the Y1R in the regulation of bone homeostasis 
 
Y1R is a GPCR-like 384 amino acid protein with a seven-pass transmembrane domain and 
a C-terminal signal transduction tail. It exhibits a high affinity for NPY and PYY but a very low 
affinity for PP and it is one of the most extensively studied Y receptors, with a wide range of 
peptide and non-peptide agonists and antagonists available and described [43].  
There is increasing evidence that NPY-induced proliferation via Y1R is a modulating 
process in the activity and growth of a wide range of cell types including among others 
vascular smooth muscle cells, neuronal precursor cells, pre-adipocytes and endothelial cells, 
mainly through the activation of ERK1/2 signalling cascade which eventually leads to 
proliferation and survival [43]. 
In bone tissue, Y1R is expressed in both OB and OC and evidences seem indicate that this 
receptor plays a crucial role in bone formation modulation[55]. Contrarily to the effect observed 
with Y2R-driven stimulation of OB proliferation, Y1R seems to have an inhibitory effect in the 
differentiation of MSC and also in the mineralization capacity of mature OBs, since MSC 
derived from Y1R germline KO mice showed an increased capacity to differentiate into OB 
when compared to MSC from wild-type mice[56]. Concerning mineralization, however, only 
Bone marrow stromal cells (BMSC) derived from mice with a mature OB-specific deletion of 
Y1R demonstrated an increase in mineral deposition in vitro, BMSC obtained from Y1R germline 
KO showed a decreased mineralization capacity [56]. The different in vitro responses of OB 
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derived from Y1R germline KO mice and from conditional OB-specific Y1R deletion indicate that 
NPY might be involved in maturation-dependent actions in the OB lineage. 
It is generally accepted that Y1R signalling inhibits OB bone forming activity, primarily 
due to evidence obtained from Y1R germline KO mice that showed a general increased cortical 
and cancellous bone formation[57]. In these experiments, Baldock et al demonstrated a 
significant increase in cancellous volume, with an increase in trabecular number and volume, 
cortical thickness and overall augmented bone formation and mineralization rates without 
changes in mineralization surfaces in both male and female mice, pointing to an intensified OB 
activity. Interestingly, OC surface was also increased in Y1R germline KO mice even though the 
overall balance of bone formation/resorption was shifted towards bone formation, which was 
not verified in Y2R germline KO mice
[57]. Moreover, hypothalamic specific Y1R deletion did not 
alter bone homeostasis, suggesting 
that Y1R acts on bone formation 
through a peripheral pathway, 
independent of hypothalamic Y1R 
signalling[57]. The effect of an Y1R 
germline and hypothalamic deletion 
is illustrated in Figure 6.  
These results are consistent 
with the findings of Lee et al where 
a conditional deletion of OB Y1R 
resulted in increased cancellous 
bone volume, trabecular number 
and thickness and enhanced OB 
activity, suggesting that OB-
specific Y1R are primarily 
responsible for the Y1R-mediated 
regulation of bone metabolism [58]. The extent of these changes, however, was not as great as 
in germline Y1R KO mice, which might point to an Y1R inhibition effect on pre-OB 
differentiation and consequent bone formation, since the deletion was specific to mature OBs 
in these mice[58].   
In the regulation of bone formation, Y1R and Y2R seem to be involved through a common 
signalling pathway since the deletion of both Y1R and Y2R does not lead to significant changes 
in cancellous bone formation when compared to Y1R KO or Y2R KO single mutants, despite 
Figure 6 – Stained sections of the distal femoral metaphysis 
of (B) Y1R germline KO mice which show an increased cancellous 
volume and cortical thickness compared to (A) a Wild type 
phenotype. (D) Hypothalamic specific Y1R deletion did not displayed 
significant differences in cancellous volume and cortical thickness 
when compared to an empty vector control (C). Bar – 1mm. 
Adopted from 
[57]
. 
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resulting in a significant increase in bone formation compared to wild-type mice[57]. The 
mineral deposition seems to be slightly decreased in double mutant mice compared to Y2R KO 
mice, but no significant changes in cortical bone were reported[57]. Interestingly, OC surface 
was not increased in double mutant mice, contrarily to what was observed in Y1R KO mice
[57]. 
Due to this lack of additive effects on bone metabolism, the involvement of Y1R and Y2R in 
bone metabolism through a common pathway was hypothesized and a proposed mechanism 
of NPY action on bone is explicit in Figure 7.  
In vitro studies have also revealed new insights on the regulation of NPY and Y1R and 
their influence on bone metabolism. NPY is secreted by neuronal cells in the proximity of the 
bone but can also be secreted by cells of the OB lineage.  Of the latter, Osteocytes are the 
main producers of NPY, as revealed through NPY immunostaining studies using GFP expression 
to differentiate between the bone cell types[59]. This NPY expression was shown to be 
modulated by glucocorticoids, since NPY mRNA expression was upregulated in osteocyte -like 
cells exposed to corticosterone[60], and also by mechanical stimuli, leading to a decrease in NPY 
expression[59]. 
In vitro, similarly with an in vivo scenario, NPY interacts with Y1R. Y1R expression in both 
calvarial OB and in OB-like MC3T3-E1 cells increases as the osteoprogenitor cells differentiate 
and mineralize in culture [59, 61, 62]. There is some controversy on whether NPY signalling 
modulates Y1R expression in culture, a decrease in expression under NPY signalling and also 
the maintenance of control levels were reported, although in these studies different cell types 
were used[54, 63]. Overall, NPY leads to the downregulation of OB specific markers such as BSP 
and osteocalcin and to a decrease in mineral deposition, according to studies using exogenous 
Figure 7 - Proposed pathway for the regulation of bone formation by hypothalamic Y2R and OBs Y1R. Y2R 
in the hypothalamus mediate NPY inhibition of bone formation through OB Y1R (A). Central Y2R specific deletion 
(B) or OBs Y1R specific deletion (C) revert bone formation inhibition. Adopted from 
[55]
. 
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NPY and also OB obtained from NPY overexpressing mice [59, 63]. Furthermore, cellular cAMP 
levels were decreased upon NPY stimulation [59]. This might be due to a G-protein receptor 
mediated adenylate cyclase inhibition and could be the underlying mechanism of modulation 
of OB differentiation, although other undiscovered signalling pathways cannot be excluded.  
On the other hand, data on the effect of NPY and Y1R signalling on OCs is still scarce. In 
vitro, in an isoprenaline stimulated OC/stromal cell co-culture model, NPY seems to inhibit 
osteoclastogenesis in a dose dependent manner, decreasing the number of TRAP positive 
Multinucleate Cells (TRAP+ MNCs) and decreasing the resorptive capacity of OC cultured in 
dentine slices. However, when stromal cells were stimulated with VitD3 or RANKL, the NPY 
inhibition was abrogated and TRAP+ MNCs number was similar to the control [64]. These results 
might be explained by the different RANKL expression pathways on stromal cells, since VitD3 
induces RANKL production through binding to an intracellular receptor that function s as a 
transcription factor whether PTH and isoprenaline induce this expression through cAMP/PKA 
signalling pathway[65], and Y1R seems to inhibit cAMP production. Nonetheless, the effect of 
Y1R signalling in osteoclastogenesis and OC gene expression remains poorly understood.  
 
Y1R antagonists and their therapeutic potential 
 
Due to its effect on bone turnover and having a peripheral action pathway instead of a 
central one, Y1R has demonstrated a great potential as a drug target to prevent or revert bone 
loss and treat certain bone disorders such as osteoporosis [43]. Some antagonists were 
developed through the study of NPY hormone family peptides, but they had limitations due to 
its proteic origin[51]. Synthetic Y1R antagonists circumvent those limitations, and in 1994 Rudolf 
and his team described for the first time the molecule ((R)-N2-(diphenylacetyl)-N-[(4-
hydroxyphenyl)methyl]-argininamide) (BIBP3226), a promising Y1R synthetic antagonist
[66]. 
BIBP3226 is a non-peptidic low molecular weight molecule that binds Y1R potently and 
selectively counteracting its normal signalling cascade, both in vitro and in vivo[67]. Despite the 
systemic administration of this compound might having serious disadvantages, a local and 
controlled release of these antagonists in the desired location through a drug carrier that 
allows cell targeting, controlled release and an extended half-life of the drug can be a good 
solution to overcome these problems. 
Besides BIBP3226, other Y1R antagonists were developed. Daniels et al developed an 
extremely potent Y1R antagonist (GR231118) that demonstrated significant effects on the food 
intake in animal models[68]. However, it is not specific because it is also an Y4 receptor agonist. 
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BIBO3304 is another promising potent compound that is highly specific for Y1R and is slightly 
less toxic than BIBP3226, and recent evidence show that an oral administration of BIBO3304 
resulted in an increased bone formation in vivo[69]. Some synthetic Y1R antagonists are listed in 
Table II. 
These compounds can prove valuable in the study of the role of the  Y1R in bone 
homeostasis and they have shown great potential as therapeutic applications in bone 
disorders. In addition to Y1R KO experiments where the Y1R central role in bone regulation was 
highlighted [54, 55, 57, 58], in vivo and in vitro studies with Y1R antagonists may reveal possible 
therapeutic applications in the prevention or treatment of degenerative skeletal diseases. Y1R 
antagonists can also have potential applications in several other disorders including feeding 
disorders, seizures, intestinal disorders and even in cancer[70]. 
 
Table II – List of synthethic Y1R antagonists 
 Compounds Description 
 GR231118 Extremely potent, however it is also a potent Y4 agonist 
 BVD-11 Highly selective and potent 
BVD-42 Highly selective and potent 
BIBP3226 Highly selective and potent, solubility/toxicity problems 
BIBO3304 Highly selective and potent, less toxic than BIBP3226 
SR 120819A Selective and potent, does not penetrate the Blood Brain Barrier 
LY357897 Selective and potent 
Benzazepine analog Selective and potent 
J-104870 Highly selective and potent 
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Aims of the Project 
 
The main objective of the current work is to study the effect of Y1R in OC differentiation 
and resorption activity. In order to achieve this goal, this project was focused in three specific 
aims: 
 Study the influence of Y1R in OC differentiation and bone resorption using an 
Y1R KO animal model. 
 Evaluate if the Y1R pathway is responsible for the observed results in OC 
derived from Y1R KO mice through Y1R blockage with a specific antagonist, BIBP3226. 
 Study the influence of OB and the Y1R pathway in osteoclastogenesis through 
the establishment of an OB/OC direct co-culture. 
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Materials and Methods 
 
1 – Cell Culture 
1.1 OC monocultures 
 Cell Extraction 
To generate primary OC, bone marrow cells were isolated from tibiae and femur of 
either 6-8 week old C57/Bl6 Wild Type (WT) mice or Y1R germline KO mice. Mice were 
euthanized through CO2 asphyxiation, followed by femur dislocation from the hip by applying 
pressure on the joint. The skin was cut around the thigh and peeled down over the foot and 
both legs were cut over the femur and washed in PBS. The ankle was cut and both tibiae and 
femur were isolated and washed on PBS + 10% Penicillin/Streptomycin + 10% Fungizone after 
muscle and fat removal. Bone extremities were cut and cells were obtained by flushing the 
bone marrow with α-MEM supplemented with 10% v/v Fetal Bovine Serum (FBS), 10U/mL 
Penicillin and 10µg/mL Streptomycin (α-MEM Complete Medium). The resulting cell 
suspension was filtered through a 70µm cell strainer (Falcon) and centrifuged for 5 minutes at 
1200 rpm and 4oC. Cells were ressuspended in 4mL α-MEM Complete Medium, plated in 
untreated petri dishes (1mL cell suspension + 4mL fresh α-MEM Complete Medium) and 
incubated for 3 days at 37oC in the presence of 30 ng/mL MCSF (PeproTech). Adherent cells 
were then detached with 0.05M EDTA in PBS for 20 minutes at 37oC, collected and centrifuged 
at 1200 rpm for 5 minutes at 4oC. 
 OC monoculture 
OC precursors were seeded at a density of 3.1x105 cells/cm2 of growth area in α-MEM 
Complete Medium. M-CSF and RANKL were added in every well at a concentration of 30ng/mL 
and 100ng/mL, respectively. Cells were incubated for 14 days changing medium every 3-4 
days. 
1.2 OB/OC direct co-cultures 
 Cell Extraction 
OCs precursors were obtained as described in section 1.1.  
OBs were harvested from new-born mouse calvaria. Neonatal mouse pups with up to 6 
days were rinsed in 70% ethanol and quickly euthanized through decapitation, followed by 
washing the heads with sterile PBS to remove blood. A cut was made in the base of the skull 
followed by a perpendicular cut on top of the skull and the removal of the skin. Calvaria was 
dissected and rinsed in α-MEM. 5 calvaria were put in 5 mL α-MEM complemented with 0.1% 
Collagenase, 0.2% Dispase II and 1% Penicillin/Streptomycin and were incubated for 10 
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minutes with agitation at 37oC. The digestion products were discarded and fresh 5mL α -MEM 
solution was added, incubating again for 10 minutes at 37oC under agitation. This second 
fraction was collected and the incubation step was repeated another 3 times, collecting 
fractions 2 to 5 in a single tube. The cell suspension was dissociated with a pipette and was 
filtered through a 70µm cell strainer to remove blood clots and cellular debris. The cell 
suspension was then centrifuged for 5 minutes at 1200 rpm at 4oC, the supernatant was 
discarded and the cells were ressuspended in 5mL of fresh α -MEM Complete Medium. Cells 
were seeded in 75cm2 flasks at a cellular density of 10x104 cells/cm2 and expanded at 37oC. 
 OB/OC direct Co-cultures 
After expansion, primary OB were seeded at a density of 2.5x104 cells/cm2 of growth 
area in α-MEM Complete Medium. 50µg/mL Ascorbic Acid 2-phosphate, 10mM β-
glycerophosphate, 10nM dexamethasone, 1000nM PGE2 and 10nM VitD3 were added to each 
well and the cells were incubated at 37oC for 24h[71]. After incubation, OC precursors were 
seeded directly on top of the adhered OB at a density of 3.1x105 cells/cm2 of growth area in α-
MEM Complete Medium supplemented with 1000nM PGE2 and 10nM VitD3 (Figure 8). Cells 
were incubated for 21 days changing medium every 3-4 days.  
1.3 Treatment with Y1R antagonist (BIBP3226) 
Cells were seeded at a density of 3.1x105 cells/cm2 of growth area in α -MEM Complete 
Medium. M-CSF and RANKL (PreproTech) were added in every well at a concentration of 
30ng/mL and 100ng/mL, respectively, and cells were treated with 60 and 1000 nM BIBP3226. 
Untreated cells were used as control. Cells were then incubated for 14 days, and the medium 
was changed every 3-4 days. All conditions were established in triplicates. 
 
 
2 - Dentine Resorption Assay 
 Dentine substrate resorption 
Resorbable Dentine Substrate Discs (OsteoSite Dentine Discs, IDS) were used for the OC 
resorption assay. Each disc was placed in an individual well of a 96-well plate and was 
incubated in α-MEM for 30 minutes at 37oC to wet the discs and facilitate cell adherence. WT 
Figure 8 – OB/OC direct co-culture model. After cell  extraction and expansion, OC 
were seeded directly on top of OB in the presence of VitD3 and PGE2. 
OB 
 
OC 
10nM VitD3  1000nM PGE2 
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and Y1R KO OC precursors were directly seeded on top of the Dentine substrate at a density of 
3.1x105 cells/cm2 of growth area in α-MEM Complete Medium, as described in section 1.1. 
Cells were then incubated for 21 days changing medium every 3-4 days. 
 Scanning Electron Microscope (SEM) analysis 
Dentine discs were washed thoroughly with PBS and transferred to 24-well plates. Each 
sample was fixed in 2.5% (v/v) glutaraldheyde (Agar) in 0.1M Sodium Cacodylate (Fluka) for 30 
minutes at RT while shaking. After fixation, Dentine discs were washed with 0.1M Sodium 
Cacodylate three times. Finally, the discs were dehydrated in serial diluted ethanol solutions of 
50, 60, 70, 80, 90 and 99% v/v, 10 minutes in each dilution, and stored in absolute ethanol. 
Each sample was then critical point dried, sputtered-coated with gold and examined by SEM. 
Pictures with a magnification of 50, 100, 500, 2000 and 5000x were obtained using back-
scattered electrons, as well as an EDS spectra of the chemical composition of the Dentine disc 
surface. Image acquisition was done at the CEMUP facilities of the Universidade do Porto.  
 3D reconstruction of the resorption pits 
After washing with PBS, Dentine discs were incubated in a 2mM EDTA solution in PBS for 
10 minutes at 37oC to remove adherent cells. They were then washed thoroughly with PBS and 
transferred to a new 96-well plate. The Dentine Discs were stained with 10µg/mL calcein in 
PBS for 30 min in the dark at RT, washed in PBS, air dried and stored at 4oC until Confocal 
Microscope analysis. 
Images were obtained in a TCS SP2 Spectral Confocal and multiphoton system (Leica) at 
a resolution of 1024x1024 pixels with a 40x oil objective. The sample was exposed to radiation 
with a wavelength of 488nm through a pinhole setting of 1 airy. Images of resorption pits 
acquired were averaged twice and stacked images with a voxel size of 
0.3662x0.3662x0.2849µm were generated. 
Resorption pit 3D reconstruction was performed with Matlab 2013a (MathWorks, USA) 
software. Stacked images were loaded into the 
program and the resorption pit outline was 
manually inputted in every stack. A mask 
containing every outline was then generated 
and used to reconstruct the resorption pit and 
to calculate the resorption pit volume, depth, 
top section area and aspect ratio. Volume was 
calculated by multiplying the number of pixels 
contained in the outlines by the voxel size. 
Figure 9 – Resorption pit measurements. Top 
Section Area (red), Depth (orange), Volume (green) and 
aspect ratio (blue) were calculated in each 
reconstructed resorption pit. 
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Depth was obtained by calculating the difference between the maximum layer index and the 
minimum layer index and multiplying by the step size  (0.2849µm), the top section area was 
calculated by multiplying the pixels in the first layer by the voxel area and finally the aspect 
ratio was defined as the ratio between the maximum length and the perpendicular maximum 
width of the pit (Figure 9).  
Resorption pits were defined as a single entity when consisting of one contiguous area 
at the surface of the dentine lacking fluorescence. Only isolated pits with clear boundaries 
were reconstructed. If the site pinched off into two or more entities at a depth greater than 
50% of its total depth, they were still considered as a single pit. Otherwise, they were treated 
as separate pits with no clear boundaries, and therefore were not reconstructed. 3D 
reconstruction was performed by plotting the 3D point set of the mask obtained with the 
resorption pit outlines and by connecting each dot with the neighbouring 6 dots. The 
generated mesh was filled and a 3D image was generated. 
 
3 - Staining procedures 
3.1 TRAP Staining 
TRAP Staining was performed using a Leukocyte Acid Phosphatase Kit ( 3-86A-1KT 
SIGMA) according to manufacturer’s instructions. Briefly, the cells were washed with PBS and 
fixed with Citrate/Acetone Solution for 30 seconds at Room Temperature (RT). They were then 
rinsed with deionized water, air dried and incubated with warm TRAP Solution (water, acetate, 
naphtol, tartrate and 1 capsule of fast garnet salt GBC) for 1h at 37oC in the dark. After 
washing with water, the cells were incubated with Acid Hematoxylin solution for 5 minutes at 
RT. Finally, the samples were washed with water and air dried. Cells were then analyzed with a 
Stereomicroscope (SZX10, Olympus) coupled to a digital camera (DP21, Olympus) or with the 
Inverted Fluorescence Microscope (Zeiss Axio Vert), where images were acquired with 
AxioCam HRc (Zeiss) and using AxioVision SE64 Rel. 4.8. software. 
 
3.2 F-Actin Staining 
To analyse cell morphology, culture medium was removed from monoculture 
experiments and the cells were washed with PBS, followed by cell fixation with 
Paraformaldheyde (PFA) (Sigma-Aldrich) 4% for 10 minutes at RT. Cells were then washed with 
PBS and permeabilized with cold Triton X-100 0.1% (v/v)(Sigma) for 5 minutes. After washing 
twice with PBS, the wells were incubated with 1% (w/v) Bovine Serum Albumine (BSA)(Sigma) 
in PBS for 1h at 37oC to block antibody unspecific binding. The cells were incubated with Alexa-
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Fluor 488 (green) Phalloidin (Life Technologies) 1:100 in PBS for 30 minutes at RT in the dark. 
At the end of the incubation time, the cells were washed with PBS and mounted using 
Vectashield with DAPI (Vector). The samples were kept at 4oC until analysis in the Inverted 
Fluorescence Microscope (Zeiss Axio Vert), where images were acquired with AxioCam HRc 
(Zeiss) and using AxioVision SE64 Rel. 4.8. software. 
OC area measurements were performed using the “measure outline” tool of the 
AxioVision SE64 Rel. 4.8. software as depicted in Figure 10. Six representative images were 
obtained from each triplicate and every cell with more than 3 nuclei and with clearly defined 
boundaries was measured as an OC. 
3.3 Alizarin Red staining and Quantification 
Calcium deposition in OB produced matrix in OB/OC co-cultures was quantified by 
alizarin red staining. Medium was removed from the wells and the cells were washed twice 
with cold PBS. Cells were then fixed in ice-cold 70% ethanol for 1 hour at -20oC, followed by air 
drying. The wells were washed twice with water and stained with fresh 2% alizarin red (Sigma) 
solution in water (pH 4.2) for 15 minutes at RT on gentle agitation. After washing the wells 
twice, they were photographed using a Stereomicroscope (SZX10, Olympus) coupled to a 
digital camera (DP21, Olympus). The stain was eluted with 10% (w/v) cetylpyridinium chloride 
(CPC)(Sigma) in sodium phosphate solution (pH 7.0) for 20 minutes at RT on gentle agitation. 
The absorbance was measured at 570nm and compared to an alizarin red standard curve.  
 
 
Figure 10 – Example of OC surface area measurement. Cells were stained with Alexa -Fluor 
488 Phalloidin and DAPI and surface area was calculated using the “measure outline” tool of the 
AxioVision SE64 Rel. 4.8. software. Only cells with more than 3 nuclei and with clear boundaries 
were measured. 
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4 – Gene Expression Analysis 
4.1 RNA extraction and purification 
Culture media from 24-well plates was discarded and 100µL of TRIzol reagent (AMBION, 
Life Technologies) were added to each triplicate. The cells were incubated for 1 minute for cell 
lysis and the sample homogenate from each triplicate was put together. RNA was purified 
using a Direct-zol RNA Miniprep kit (Zymo Research) according to manufacturer’s instructions. 
Briefly, 1 volume of ethanol (100%) was added to the sample homogenate in TRIzol, it was 
mixed by vortexing and loaded directly into a Zymo-Spin IIC Column in a Collection Tube. A 
series of washing procedures with Wash Buffers followed by centrifugation at 12000 rpm for 1 
minute were performed. The RNA was eluted using DNase/RNase-Free water and stored at -
80oC. 
 
4.2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
The SuperScript II First Strand Synthesis Kit (Invitrogen) was used to synthetize cDNA. 
RNA concentration was normalized for 250ng (OC monoculture RNA) and for 500ng (OB/OC co-
culture RNA) and filled up to 8µL with DEPC-treated water. 1µL of 10mM oligo(dTs) primer and 
1µL of 10mM dNTPs were added to the RNA mix. Denatured the RNA/primer mixture at 65oC 
for 5 minutes and placed the samples on ice for 1 minute. Added 9µL of a reaction mix 
composed of 2µL of 10x RT-Buffer, 4µL of 25mM MgCl2, 2µL of 0.1M DTT and 1µL of RNase out 
(40U/µL). Incubated the samples at 42oC for 2 minutes, after which 1µL of SuperScript II RT 
was added to each tube. cDNA synthesis was carried out for 50 minutes at 42oC. The reaction 
was then terminated at 70oC for 15 minutes, followed by chilling on ice. 1µL of RNase H was 
added to each tube and they were further incubated at 37oC for 20 minutes to eliminate 
reminiscent RNA. cDNA was stored at -20oC. 
 
4.3 Polymerase Chain Reaction (PCR) 
cDNA was amplified using the HotStarTaq PCR kit (Qiagen) according to manufacturer’s 
instructions. Briefly, a reaction mix was prepared using 5µL of 10x concentrated PCR buffer 
containing 15mM MgCl2, 1µL of 10mM dNTPs, 1µL of primer pairs (10µM), 0.25µL of 
HotStarTaq DNA Polymerase and filled up to 49µL of sterile distilled water. Primers were 
designed using the NCBI Primer-BLAST tool and synthetized by Invitrogen (Table III). All primer 
pairs were located in different exons to only ensure the amplification of correctly spliced 
mRNA. 1µL of template DNA was added to the previous mix. PCR was carried out in a 
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TPersonal Thermocycler (Biometra) with the following cycling conditions: enzyme was 
activated at 95oC for 15 min, followed by 35 cycles of sequential cDNA denaturation at 94oC for 
1 min, annealing at 58oC for 1 min and extension at 72oC for 1 min. A final extension step at 
72oC for 6 min was performed in the end and the samples were kept at 4oC. 
PCR products were run on Ethidium Bromide stained 3.5% agarose (Lonza) gels using a 
PowerPac Basic Electrophoresis System (Bio-Rad) together with a HyperLadder V (Bioline) 
molecular weight marker. Gels were scanned on a GelDoc XR+ imaging system (Bio-Rad) under 
UV light and analysed using ImageLab Software (Bio-Rad).  
 
Table III – Primer pair sequences for murine gene analysis. 
Gene Forward Primer (5’->3’) Reverse Primer (5’->3’) 
Genbank 
Acession 
Number 
Annealing 
Temperature 
(oC) 
Product 
Length 
GADPH GCCTTCCGTGTTCCTACC AGAGTGGGAGTTGCTGTTG NM_008084 58 183 
TRAP5 CGACCATTGTTAGCCACATACG TCGTCCTGAAGATACTGCAGGTT 
NM_00110240
5.1 
58 77 
CTR AGTTGCCCTCTTATGAAGGAGAAG GGAGTGTCGTCCCAGCACAT NM_007588.2 58 76 
 (OSCAR) TGGCGGTTTGCACTCTTCA GATCCGTTACCAGCAGTTCCAGA NM_175632 58 199 
CATK ATATGTGGGCCAGGATGAAAGTT TCGTTCCCCACAGGAATCTCT NM_007802.4 58 90 
RANK GGACAACGGAATCAGATG CCACTACTACCACAGAGAT NM_009399.3 58 123 
RANKL CCCATCGGGTTCCCATAAAGT AGCAAATGTTGGCGTACAGG NM_011613.3 58 114 
OPG GTGGAATAGATGTCACCCTGTGT TTTGGTCCCAGGCAAACTGT NM_008764.3 58 110 
DC-STAMP AAGCGGAACTTAGACACAGGG CAGCTAGGGCTTCGTGGAAA NM_029422 58 101 
Atp6v0d2 TTCTTGAGTTTGAGGCCGAC CAGCTTGAGCTAACAACCGC NM_175406 58 144 
CD9 GCTGGGATTGTTCTTCGGGT GCTTTGAGTGTTTCCCGCTG NM_007657 58 171 
CD47 CGATGCCATGGTGGGAAACT TCAGTGTTGAAGGCCGTGC NM_010581 58 99 
MCP1 AGCCAACTCTCACTGAAGCC GCGTTAACTGCATCTGGCTG NM_011333 58 131 
Y1R CTCGCTGGTTCTCATCGCTGTGGAACGG GCGAATGTATATCTTGAAGTAG NM_010934.4 60 325 
 
4.4 Real-Time quantitative Polymerase Chain Reaction (RT-qPCR) 
RT-qPCR was performed in a iCycler iQ5 Real-Time PCR Detection System (Bio-Rad) and 
data was analysed using iQ5 software (Bio-Rad). RT-qPCR was carried out in a 20µL reaction 
volume containing 10µL of iQ SYBR Green supermix (Bio-Rad), 1µL of cDNA template and 
10µM primer pairs. The used supermix was composed of dNTPs, SYBR Green I dye, hot-start 
iTaq DNA Polymerase, qPCR buffer solution and stabilizers.  
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The following cycling conditions were performed: the enzyme was activated at 95oC for 
3.30 min, followed by 40 cycles of sequential cDNA denaturation at 95oC for 30s, annealing at 
58oC for 30s and extension at 72oC for 30s. The final step was the determination of the melting 
curve at 55-95oC for 10s/step. 
For data analysis, the comparative threshold (CT) cycle values for constitutively 
expressed Glyceraldehyde 3-phosphate dehydrogenase (GADPH) to normalize loading 
variations. The expression fold difference was calculated according to Eq.1.  
 
mRNA relative Expression = 2 (CTcontrol – CT)      (Eq.1) 
     
Primer efficiency was assessed by a linear regression of the CT values of a cDNA 
template serial dilution and primers were considered efficient with efficiency values of 90-
105%. 
5 - Statistical Analysis 
All results are expressed as mean ± SEM. Normal distribution of the data was assessed 
through Shapiro-Wilk test. Statistical differences between groups were compared using a two-
way ANOVA and post hoc comparisons were performed with an Independent-samples t-test. 
When normal distribution was not verified, the non-parametric Kruskal-Wallis test followed by 
the Mann-Whitney U-test to assess statistical significance were performed. Statistical analysis 
was carried out with SPSS for Windows, version 20 (SPSS Inc., Chicago, IL, USA) and a p<0.05 
was accepted as being statistically significant. 
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Results and Discussion 
1 – The role of Y1R in Osteoclastogenesis and OC resorption capacity 
 
1.1 Expression of Y1R during Osteoclastogenesis 
 
Y1R presence in WT OC was confirmed by PCR and RT-qPCR, which revealed an increase 
in Y1R expression during OC differentiation (Figure 11). Undifferentiated pre-OC do not show 
measurable levels of Y1R mRNA, while Y1R expression is non significantly increased at day 7 and 
day 14 of culture.  Since Y1R expression was verified in these cells, further testing with this 
receptor ensued. 
 
 1.2 The effect of Y1R gene deletion on Osteoclastogenesis 
 
Y1R KO mice demonstrated an increase in OC surface on cancellous bone when 
compared to control animals, suggesting an effect of Y1R signalling on the modulation of 
osteoclastogenesis[57]. However, the impact of Y1R deficiency on OC maturation is still 
unknown. Therefore, primary bone marrow flushed cells either from WT or Y1R KO mice were 
cultured for 14 days in the presence of M-CSF and RANKL to promote OC maturation. TRAP 
expression and morphology analysis was performed at culture day 7 and 14, where cells with 
more than 3 nuclei were considered OC. 
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Figure 11 - Expression of Y1R in WT cells. Maturation of bone marrow derived pre-OC was induced with M-
CSF and RANKL for 14 days in 24-well culture plates. mRNA was collected at the given time points from 3 
replicates. (A) Expression of Y1R at day 1, 7 and 14 of culture. (B) Quantification of Y1R expression in WT cells 
relative to GADPH constitutive expression. Results are expressed as mean ± SEM from 2 independent 
experiments. 
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TRAP staining results are shown in Figure 12. At day 7, Y1R KO wells  revealed a relative 
increase in number of TRAP+ MNCs compared to control conditions, albeit statistically non-
significant (Figure 12C). After 14 days, however, TRAP+ MNC numbers increased significantly in 
Y1R KO wells. Microscopic analysis also shows a relative increase in size of Y1R KO OCs 
compared to WT OCs (Figure 12B). These results are consistent with previous reports of a 
decrease in TRAP+ MNC numbers with NPY stimulation[64], thus the increase in TRAP+ MNCs is 
to be expected in the absence of NPY signalling through Y1R in Y1R KO OCs. NPY is therefore a 
negative regulator of pre-OC fusion such as OPG and Calcitonin[72], which also revealed a 
decrease in TRAP+ MNCs[73, 74], , although these changes might be implemented through 
different signalling pathways.  
Similarly to other NPY receptors, it is generally accepted that Y1R signalling cascade 
triggering leads to adenyl cyclase and Ca2+ channel inhibition and to PI3K and ERK1 activation, 
promoting transcriptional regulation[75]. Interestingly, Hotokezaka and co-workers reported an 
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Figure 12 – TRAP Staining of Y1R KO OCs. Maturation of bone marrow derived pre-OC was induced with M-CSF and RANKL 
for 14 days. Representative images of (A) WT and (B) Y1R KO cells at (1) day 7 and (2) day 14 time points are presented. Whole well  
images are shown on the left and images taken with the microscope with a 10x objective are shown on the right. Scale bar, 100 µm. 
(C) Number of TRAP
+
 MNCs. TRAP
+
 OC with more than 3 nuclei were counted. Results are expressed as mean ± SEM from 3 
independent experiments. Groups were compared through ANOVA and independent-samples t-test with * p<0.05. 
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increase in osteoclastogenesis and TRAP intensity in OC-like cells incubated with specific 
Mitogen-activated protein kinase (MAPK) ERK kinase (MEK) inhibitors, which would inhibit 
MEK from phosphorylating and activating ERK1[76]. Thus, a decrease in osteoclastogenesis and 
TRAP+ MNC numbers could be due to ERK1 activation, which is part of the Y1R signalling 
pathway. ERK1 inhibition is consistent with the results observed in the absence of Y1R. 
In addition, immunostaining of cytoskeletal F-actin was used to analyse Y1R KO OC 
morphology in comparison to control samples (Figure 13). Day 7 time point images revealed 
few and relatively small OC when compared to those of day 14 time point,  suggesting that 7 
days it is not enough to allow differentiation of pre -OC using this protocol.  Pre-OC are 
rounded cells with a diameter around 30-50µm that are visible throughout the surface of the 
wells in every image, whereas other cells with fibroblast-like aspect such as the ones pointed 
with a red arrow (Figure 13A2, 13B2) might be BMSCs or MSCs that differentiated towards 
other cell types than pre-OC. A primary cell culture is mostly heterogeneous since it is hard to 
purify the cell types extracted from the bone marrow, which might explain the presence of the 
different cell types in culture (red arrows). Protocol modifications should be implemented in 
order to reduce these cell contaminations. Analysis of the wells at the day 14 time point 
showed an obvious increased size of mature Y1R KO OCs when compared to WT OCs, 
suggesting an increased fusion capacity of Y1R KO pre-OC. Differences in differentiation 
capacity cannot be concluded since cells from both genotypes were capable of differentiating, 
with comparable cell numbers. Mature OC pointed with a white arrow show typical OC 
morphology: a multinucleated cell with a characteristic actin ring in the sealing zone, with 
higher concentration of F-actin in the perimeter of the cell when compared to the cytoplasm. 
Interestingly, measurement of OC section area revealed a statistically significant 
increase in the area of Y1R KO mature OCs when compared to WT cells, but only on day 14 
time point (Figure 13C). This increased section area is probably due to increased motility or 
fusion protein expression by Y1R KO pre-OC. 
 
1.3 The effect of Y1R KO on OC Resorption Capacity 
 
A previous study with isoprenaline treated stromal cell/OC co-culture has shown a 
decreased OC resorption of dentin slices upon NPY stimulation[64]. In order to verify the effect 
of Y1R on OC resorption capacity, primary bone marrow flushed cells from WT and Y1R KO mice 
were seeded directly on top of dentine substrates on 96-well plates and were cultured for 21 
days under M-CSF and RANKL stimulation. After fixation, critical -point drying and gold-
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sputtering, each dentine disc was analysed at the SEM (Figure 14). A control dentine disc 
without cultured cells can be found in the Annex (Figure 32).  
Back-scattered electron images revealed a decrease in number and area of resorption 
pits on dentine discs cultured with Y1R KO OC when compared to WT controls. In addition, this 
back-scattered electron image formation mode is based on the collection of back-scattered 
C 
A1 
B2 B1 
A2 
Figure 13 – Morphological analysis and section area quantification of Y1R KO OCs. Maturation of bone marrow derived 
pre-OC was induced with M-CSF and RANKL for 14 days. Representative images of (A) WT and (B) Y1R KO cells at (1) day 7 and (2) 
day 14 time points are presented, taken with a 10x objective. F-actin and nuclei were labelled with green and blue, respectively. 
Large, multinucleated cells were considered mature OC (white arrows). Other cell  types were also present in culture (red arro ws). 
Scale bar, 100µm. (C) Quantification of the mature OC section area by genotype. Results are expressed as mean ± SEM from 3 
independent experiments with a total day 7 n = 179, 62, 109 ; 123, 126, 119 (WT; Y1R KO) and day 14 n = 170, 39, 145 ; 90, 148, 
166 (WT; Y1R KO) cells measured. Groups were compared through Kruskal-Wallis and Mann-Whitney U-test with * p<0.05. 
A
v
e
r
a
g
e
 O
C
 A
r
e
a
 (

m
2
)
D
7
D
1
4
0
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
4 0 0 0 0
W T
Y 1 R  K O
*
 
     30 
 
electrons from the sample, which are released with discrete and defined energy depending on 
the atomic number of the atoms excited by the electron beam. Thus, as atoms with low atomic 
number require higher energy to release surface electrons, these electrons are released with 
lower energy and originate darker points in the image. Contrarily, surface electrons from high 
atomic number atoms are easily released (farther away from the atom’s protons) and are 
collected with a higher energy, originating brighter points in the image [77]. Dentine discs are 
constituted by a mineralized collagen matrix, where collagen is covered by a hydroxyapatite 
layer. After resorption, the bright phosphate and calcium of the dentine’s surface (higher 
atomic number) is replaced by darker regions of collagen (carbon, lower atomic number). An 
image of the collagen fibres exposed by the resorption can be found in the Annex.  Carbon-rich 
cellular remains might be found in some areas, such as the ones signalled by white arrows 
(Figure 14B), and they seem to cover parts of the dentine surface, probably due to errors 
occurred in the critical-point drying of the samples. 
The dentine disc surface can be analysed with an EDS spectra, where the discrete energy 
of the back-scattered electrons is used to obtain the surface atomic composition up to few 
nanometers deep. As expected, Phosphate and Calcium peaks are higher in dentine surfaces 
and the carbon peak is higher in the pit surface than in dentine surface due to the exposure of 
collagen fibres, mainly constituted by carbon. 
Considering that darker regions correspond to exposed collagen, WT resorption pits 
seem to be deeper than Y1R KO ones since the latter are relatively brighter. This is consistent 
with the EDS spectra of the resorption pits, where the difference between the oxygen, 
phosphate and calcium peaks in the surface of the dentine disc and in the pits derived from 
WT OCs is steeper than in those derived from Y1R KO OCs (Figure 14C, D). This might suggest a 
higher exposure of collagen fibres and more successful demineralization in dentine discs 
derived from WT OCs when compared to those derived from Y1R KO OCs. 
In order to obtain more quantifiable results, OC-generated resorption pits were 
reconstructed from Confocal Microscopic images using an original Matlab program. The resul ts 
are demonstrated in Figure 15.  
The measurements of resorption pits revealed a marked difference between WT and Y1R 
KO OC resorption pits, with a statistically significant decrease in either Volume, Top Section 
Area and Depth of Y1R KO derived resorption pits when compared to WT ones. 3D 
reconstruction confirmed that WT resorption pits are deeper and wider than Y1R KO resorption 
pits, and therefore a greater volume. Y1R KO pits are shallower, which could indicate an 
impaired resorption capacity. These results are consistent with the previous SEM analysis.  
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Figure 14 – SEM analysis and EDS spectra of dentine discs after culture with WT and Y1R KO OCs. 
Bone marrow derived pre-OC were seeded directly on dentine discs and stimulated with M-CSF and RANKL 
for 21 days. Representative SEM images of (A) WT and (B) Y1R KO OC cultured dentine discs were taken after 
21 days of culture with 500x and 2000x magnification. There are some cellular remains visible on Y1R KO OC 
cultured dentine discs (white arrows). Images were obta ined through the collection of back-scattered 
electrons. (C) WT and (D) Y1R KO OC cultured dentine disc EDS spectra where dentine surface (Z1 -red) and 
pit surface (Z2-green) are compared. 
A B 
C 
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Figure 15 – Y1R KO resorption pit 3D reconstruction. Bone marrow derived pre-OC were seeded directly on dentine discs and 
stimulated with M-CSF and RANKL for 21 days. Dentine discs were stained with calcein and observed at the Confocal Microscope 
under 488nm radiation. Representative reconstruction of (A) WT and (B) Y1R KO resorption pits. 3D reconstruction was performed 
with Matlab software using the stacked images obtained at the microscope with a 40x objective. Images had a resolution of 
1024x1024 pixels and a z-step of 0.2849 µm. (C) Resorption pit Volume,  (D) Top section area and (E) Depth. Results are expressed as 
mean ± SEM from N (WT; Y1R KO) = 2; 3 independent experiments. n = 13 resorption pits were used from each mouse. Groups were 
compared through Kruskal-Wallis test and Mann-Whitney test with * p<0.05 (F) Scatter plot of resorption pit Top Section Area 
against Depth and (G) Depth and (H) Aspect Ratio against resorption pit Volume. 
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Interestingly, by plotting the Top Section Area vs Resorption Pit Depth it is clear that 
with increasing Depth the Top Section Area does not increase as much in Y1R KO pits, resulting 
on a graphic distribution shifted to the bottom (Figure 15F). In WT samples, measurements are 
more evenly distributed. This could mean that impairment in OC resorption capacity is more 
significant in lateral resorption than in vertical resorption, although both are affected. A similar 
distribution can be seen in a Depth vs Volume scatter, where the distribution of dots is shifted 
to an increasing Depth rather than homogenous distribution such as the one verified in WT OC 
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resorption pits.  
Another interesting measure is the Aspect Ratio of the resorption pits. Aspect ratio is 
calculated by dividing the maximum Length of a resorption pit by the maximum perpendicular 
size and it can relate to the circularity of the resorption pit section area, where an Aspect Ratio 
of 1 corresponds to an approximately circular section area. As observed in Figure 15H, Y1R KO 
resorption pits seem to be distributed far from the 1 value (black line), where WT p its are 
distributed around the 1 value, with some values farther from 1. This could point to a 
preferable direction of resorption by Y1R KO OC leading to elliptical resorption pits rather than 
circular ones. 
Dentine resorption could be influenced by either intrinsic factors such as genomic 
expression or by extrinsic factors such as the composition and topography of the material to 
be resorbed. Goldberg and her team studied the influence of the Rho GTPases Rac1 and Rac2 
on the resorption behaviour of mice OC[78]. Rac1 and Rac2 regulate motility and cytoskeleton 
rearrangement and a decrease in resorption pit volume was reported in Rac1 and Rac2 KO 
mice. Interestingly, Rac1 KO mice demonstrated reduced pit depth and surface area while Rac2 
KO mice only demonstrated reduced pit depth, suggesting different roles of these proteins on 
the process of bone resorption. Goldberg also reported a WT mean resorption pit volume of 
approximately 11000 µm3, which is far greater than the one obtained in this project. This was 
probably due to the use of dentine discs from different origins.  
On the other hand, resorption can be influenced by the resorption substrate [79] and 
Rumpler and co-workers demonstrated that dentine substrates suffer higher resorption than 
bone substrates[80]. This difference seems to be due to increased osteoclastogenesis in dentine 
surfaces and not due to increased resorption, since resorption pit size is similar in both 
substrates[80]. In this work, material composition cannot be the influencing factor since the 
resorbed material was the same in each condition. Rumpler also proposed a resorption trail 
formation model, which leads to the formation of trails with a preferential directio n and 
constant depth. In addition, Rumpler observed that actin ring organization was different in 
resorption pit and trail formation, leading to different resorption orientation [80]. Therefore, a 
different actin rearrangement could be responsible for the observed differences in resorption 
pit shape. 
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1.4 Y1R KO OC Gene Expression  
 
In order to have a better understanding on changes observed in previous morphology 
and resorption analysis, the expression of several key markers for OC differentiation, fusion 
and bone resorption were studied. Primary bone marrow flushed cells were seeded on 24-well 
plates under M-CSF and RANKL stimulation for 14 days. mRNA was extracted at day 7 and day 
14 time points, following cDNA synthesis and amplification. 
Differentiation Markers 
The analysis of specific OC differentiation markers in Y1R KO cells has revealed an 
apparent decrease in their expression when compared to their WT counterparts (Figure 16). 
TRAP expression exhibited a slight decrease in expression in the first 7 days of culture in Y1R 
KO OCs. At day 14, however, the decrease in TRAP expression in Y1R KO OCs is more 
pronounced, with a decreasing trend when compared to WT OCs. Although non-significant, 
this result is consistent with the previous resorption assays, where Y1R KO OCs demonstrated 
A      B 
 
 
 
 
 
 
C      D 
Figure 16 – Expression of OC differentiation markers in Y1R KO OC. Maturation of bone marrow derived pre-OC 
was induced with M-CSF and RANKL for 14 days in 24-well culture plates. mRNA was collected at the given time points 
from 3 replicates. (A) TRAP, (B) CTR, (C) OSCAR and (D) CATK gene expression quantification relative to GADPH 
constitutive expression. Results are expressed as mean ± SEM from 3 independent experiments. Groups were 
compared through ANOVA and independent-samples t-test, except CTR expression that was compared through 
Kruskal-Wallis and Mann-Whitney U-test, with * p<0.05. 
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an inferior resorption capacity. TRAP is an acidic phosphatase released into the resorption 
sealing zone and is partially responsible for the bone demineralization process, thus its 
downregulation could explain the observed reduced bone resorption.  Other studies also 
reported a deficient OC resorption activity due to TRAP inhibition [81] and a correlation 
between cell size and TRAP activity, where larger osteoclastic giant cells had a decreased TRAP 
activity[82], which is consistent with the increased OC area and decreased TRAP expression 
observed. 
CTR is another typical OC marker, and its expression did not significantly change during 
14 days of culture and OC differentiation. CTR exerts an inhibitory action upon activation and 
its expression is very low in comparison to the housekeeping gene. CTR expression in Y1R KO 
cells did not show statistically significant differences during OC differentiation, with a high 
associated error between experiments. Thus, CTR expression does not seem to be influenced 
by the absence of Y1R. 
OSCAR is a transmembrane receptor specific for OC that is expressed during early stages 
of OC differentiation and it is required for osteoclastogenesis together with M-CSF and RANKL 
stimulation[83]. OSCAR expression displayed a decreasing trend in Day 14 time point, although 
it was not statistically significant. Since OSCAR expression is induced by NFATc1[84], a 
transcription factor that is in turn involved in the RANK signalling cascade [85], changes in the 
RANK/RANKL signalling pathway could be responsible for the slight decreasing trend observed 
in OSCAR expression. 
Finally, CATK is expressed in a RANKL dependent manner during OC differentiation and it 
is a fundamental enzyme in the resorption process, being responsible for bone matrix collagen 
degradation. Y1R KO OCs show a significant downregulation of CATK expression at day 7 time 
point, where the production of CATK mRNA is nearly halved when compared to the expression 
in WT controls. However, no statistical differences were found at day 14 time point, which 
point to a slight recovery in CATK levels. CATK levels in Y1R KO cells remained constant 
throughout the experiment, while WT levels decreased with time. This could result from a 
time-dependent decrease in resorption capacity of WT cells, however no evidence of such 
decrease is apparent in the resorption assays performed previously. Similarly to TRAP 
expression, these results are consistent with those obtained in the dentine resorption assays, 
which might be explained by CATK downregulation and subsequent collagen degradation 
impairment. Interestingly, J.H. Kang and co-workers reported an increase in OC area and a 
decrease in resorption capacity after OC produced OPG silencing[74]. These authors have shown 
that OC can produce OPG to intrinsically limit osteoclastogenesis, and that the OPG silencing 
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resulted in a downregulation of TRAP and CATK even though there was an increase in OC area, 
similar results to those shown in this project. Thus, the absence of Y1R signalling might 
interfere with the RANK/RANKL axis with similar end results as OPG signalling, although other 
signalling pathways must be explored. For instance, calcitonin was shown to downregulate OC 
resorption through Protein Kinase A(PKA) and PKC activation in mice[86]. The latter results are 
consistent with the absence of Y1R signalling since Y1R activation leads to adenyl cyclase and 
Ca2+ channel inhibition, which then decreases PKA and PKC activity and therefore an increased 
resorption compared to Y1R KO mice. 
Fusion Proteins 
To complement the TRAP staining and morphological analysis, the expression of several 
genes responsible for pre-OC fusion was explored (Figure 17). Of the genes analysed, only 
MCP1 has been significantly upregulated in Y1R KO cells. DC-STAMP expression has shown a 
A       B 
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    E 
Figure 17 – Expression of pre-OC fusion genes in Y1R KO cells. Maturation of bone marrow derived pre-OC was 
induced with M-CSF and RANKL for 14 days in 24-well culture plates. mRNA was collected at the given time points from 
3 replicates. (A) DC-STAMP, (B) Atp6v0d2, (C) CD9, (D) CD47 and (E) MCP1 gene expression quantification relative to 
GADPH constitutive expression. Results are expressed as mean ± SEM from 3 independent experiments. Groups were 
compared through ANOVA and independent-samples t-test with * p<0.05. 
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statistically significant downregulation in Y1R KO cells, which is unexpected taking in to account 
the increased OC area and TRAP+ MNCs observed in previous results. 
DC-STAMP is a RANKL-dependent transmembrane protein which is fundamental in pre-
OC fusion but it is not directly involved in OC differentiation [25, 87]. Its expression is regulated 
primarily by the RANKL-induced transcription factors NFATc1 and c-Fos and they promote cell-
to-cell fusion by binding to a yet unknown ligand[88]. Since Y1R signalling might interfere with 
RANKL pathway, this decrease in expression could be explained by the DC-STAMP dependence 
of RANKL signalling, but the decrease in expression was not verified for CD9 and Atp6v0d2 
which are also RANKL-dependent[23]. Furthermore, a decrease in resorption pit formation was 
reported in an OC-like RAW-D cell line after the addition of an anti-DC-STAMP antibody[89], 
suggesting a role of DC-STAMP in the resorption activity which could explain the decreased 
resorption observed previously in this work. However, TRAP+ MNC number was also decreased 
with the addition of the same antibody, which is disagreeing with the increase in TRAP + MNCs 
verified in Y1R KO OCs. 
Atp6v0d2, CD9 and CD47 gene expression by Y1R KO cells was similar to control levels in 
all time points, with the exception of a slight decreasing trend of the expression of CD47 at day 
7. 
Atp6v0d2 is a component of the v-ATPase involved in pre-OC fusion that exerts its 
function through direct cell-to-cell contact but not directly involved in the proton pump 
activity[26]. Nonetheless, the similar Atp6v0d2 levels between Y1R OCs and WT OCs might also 
point to similar levels of v-ATPase, which could mean that a deficient acidification of the  
sealing zone is not the factor responsible for the impaired resorption activity observed in Y 1R 
OCs. Confirmation is required in future studies, though. Likewise, the increase in OC area and 
fusion in Y1R KO cells is not accountable to an increase in Atp6v0d2 expression levels. 
CD9 and CD47 are membrane proteins involved in cell fusion and cell recognition, 
respectively. CD9 expression is enhanced by RANKL signalling and it is located at lipid rafts in 
the cellular membrane, being involved in cell fusion [23]. CD9 mRNA expression in Y1R KO OCs 
was similar to control levels, thus it does not seem to be responsible for the increased fusion 
observed in those cells. CD47 is an integrin-associated protein that binds to another receptor 
involved in cell fusion, the Macrophage Fusion Receptor (MFR), and it mediates cell -cell 
recognition instead of cell-cell fusion[23]. Similarly to CD9 and despite the slight decreasing 
trend in CD47 expression in Y1R KO cells at day 7, CD47 does not seem to be responsible for 
the increased fusion in Y1R OC cells. 
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Lastly, at day 7 there is a non-significant, slight increase in the expression of MCP1 in Y1R 
KO cells. Moreover, MCP1 expression was significantly increased in Y1R KO OC at the day 14 
time point. MCP1 is a chemokine that binds C-C Receptor 2 and is involved in the recruitment 
of leukocytes during acute inflammation but it has also been reported to be involved in OC 
differentiation in a RANKL dependent manner[90]. Several studies with MCP1 KO mice have 
shown that MCP1 facilitates OC fusion and maturation, since the absence of MCP1 signalling 
led to decreased TRAP+ MNC counts in vitro and decreased bone resorption in vivo[91-93]. In 
addition, MCP1 together with M-CSF is able to induce the formation of CTR+ TRAP+ MNCs 
without RANKL stimulation, although the obtained OCs are not able to resorb bone [94]. 
Furthermore, OC express MCP1 and it regulates OC fusion and differentiation in an 
autocrine/paracrine way, although its action is not independent from other factors such as DC-
STAMP[95]. Hence, MCP1 upregulation in Y1R KO cells might be responsible for an increased 
motility and cell fusion, leading to increased OC area and TRAP+ MNC numbers in these cells.  
A study using monocytes where MCP1 was downregulated after Janus kinase 
(JAK)/signal transducer and activator of transcription (STAT) and p38 MAPK inhibition could 
enlighten the mechanism underlying RANKL-dependent upregulation of MCP1[96]. Considering 
that DC-STAMP and MCP1 are regulated by different transcription factors, although both being 
RANKL dependent, and that MCP1 is a soluble chemokine which acts independently of cell-cell 
contact, the decrease in DC-STAMP mRNA levels and increase in MCP1 mRNA observed in Y1R 
KO OCs is not contradictory and could explain the increase in OC section area.  However, other 
factors involved in OC fusion such as a disintegrin and metalloprotease (ADAM) 8 and 12, MFR 
and triggering receptor expressed on myeloid cells 2 (TREM2) should not be excluded and 
should be analysed in future studies. 
 
2 - Y1R antagonism in Osteoclastogenesis and OC resorption capacity 
 
To verify if the Y1R pathway is responsible for the observed results in Y1R KO OCs, OC 
behaviour was analysed after Y1R blockage. Non-peptidic Y1R antagonists have shown 
promising results in in vivo experiments regarding an increase in bone formation, similarly to a 
Y1R KO phenotype
[69]. To achieve this specific aim, the Y1R antagonist BIBP3226 was chosen 
due to its high specificity. 
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2.1 The effect of Y1R antagonist stimulation in Osteoclastogenesis 
 
To assess the effect of Y1R antagonism on Osteoclastogenesis, primary bone marrow 
flushed cells from WT mice were cultured for 14 days in the presence of M-CSF and RANKL to 
promote OC maturation. Soluble Y1R antagonist BIBP3226 was added to cultures at increasing 
concentrations of 0, 60 and 1000nM. Untreated cells were used as control. TRAP staining and 
morphological analysis was performed at day 7 and day 14 time points, where cells with more 
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Figure 18 - TRAP Staining of BIBP3226 treated cells. Maturation of bone marrow derived pre-OC was induced with M-CSF and 
RANKL for 14 days in the presence of 60nM and 1000nM BIBP3226. Untreated cells were used as control. Representative images of (A) 
0nM, (B) 60nM and (C) 1000nM BIBP3226 treated cells at (1) day 7 and (2) day 14 time points are presented. Whole well images are 
shown on the left and images taken with the microscope with a 10x objective are shown on the right. Scale bar, 100µm. (D) Number of 
TRAP
+
 MNCs. TRAP
+
 OC with more than 3 nuclei were counted. Results are expressed as mean ± SEM from 3 independent experiments. 
Groups were compared through paired t-test with * p<0.05. 
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than 3 nuclei were considered mature OC. 
BIBP3226 treatment led to a statistically significant increase in TRAP+ MNC numbers in 
day 7 time point, independently of the tested concentration (Figure 18). However, at day 14 
cells treated with 1000nM BIBP3226 only revealed a non-significant increasing trend when 
compared to control levels, while treatment with 60nM BIBP3226 maintained a significant 
increase in TRAP+ MNCs. Microscopic images revealed an increase in size and number of 
differentiated OC after BIBP3226 treatment when compared to control conditions (Figure 18B-
C). These results suggest that Y1R specific antagonism lead to an upregulation of OC 
differentiation and fusion, similarly to the increased fusion observed in Y1R KO OCs. However, 
this increase in TRAP+ MNCs seems to develop at an earlier stage than in Y1R KO OCs, since at 
day 7 there is already an increase in TRAP+ MNCs. Furthermore, at day 14 there seems to be a 
decrease in TRAP+ MNCs in wells treated with 1000nM BIBP3226, which might point to a 
inhibitory mechanism of BIBP3226 in high doses at later stages of differentiation or a recovery 
towards control levels.  Toxicity of 1µM BIBP3226 in a kidney cell line has been reported 
previously[97]. Nevertheless, since the affinity of BIBP3226 to Y1R is extremely high with a Ki of 
less than 8nM (which means that a concentration of 8nM would bind to 50% of the available 
Y1R, displacing the natural agonists)
[98], total antagonism can be achieved with low BIBP 
concentrations and thus decrease BIBP3226 toxic effects, if existent. However, a cytotoxicity 
evaluation using rezazurin assay was performed previously and did not show any significant 
differences between BIBP3226 treated cells and controls (Data not shown).  
As performed with Y1R KO cells, immunostaining of cytoskeletal F-actin was used to 
analyse the effect of BIBP3226 in cell morphology (Figure 19). At day 7, there are no striking 
differences between BIBP3226 treated cells and control ones, with many undifferentiated pre-
OC and few OCs visible (white arrows). Day 14 time point images show large differentiated OC 
in both 60nM and 1000nM BIBP3226 treated cells, where60nM BIBP3226 treated OCs seem to 
be larger. Morphological traits do not seem to be different between OC subjected to different 
treatments.  
OC section area analysis has shown no differences at both the  analysed time points 
between treatments but there is a slight increase in 60nM BIBP3226 treated OCs in  
comparison with controls at day 14 (Figure 19C), although in a much lesser extent than what 
was verified in Y1R KO OCs. Interestingly, antagonist overstimulation of Y1R with1000nM 
BIBP3226 led to a decrease in OC area compared to 60nM BIBP3226 treatment at day 14. 
These results are consistent with the TRAP staining performed previously,  where the same 
pattern of OC differentiation after BIBP3226 treatment is observed at day 14.  
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NPY binds to Y1R leading to adenyl cyclase inhibition, among other effects. BIBP3226 
treatment was shown in previous studies to counteract NPY driven cAMP inhibition,  consistent 
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Figure 19 – Morphological analysis and section area quantification of BIBP3226 treated cells. Maturation of bone 
marrow derived pre-OC was induced with M-CSF and RANKL for 14 days in the presence of BIBP3226. Untreated cells were 
used as control. Representative images of (A) 0nM, (B) 60nM and (C) 1000nM BIBP3226 treated  cells at (1) day 7 and (2) day 
14 time points are presented, taken with a 10x objective. F-actin and nuclei were labelled with green and blue, respectively. 
Large, multinucleated cells were considered mature OC (white arrows). Other cell  types were also present in culture (red 
arrows). Scale bar, 100µm. (C) Quantification of the mature OC section area by treatment. Results are expressed as mean ± 
SEM from 3 independent experiments with a total day 7 n (0nM; 60nM; 1000nM) = 179, 62, 109 ; 224, 108, 110; 239, 164, 113 
and day 14 n (0nM; 60nM; 1000nM) = 170, 39, 145; 148, 41, 125; 181, 62, 115  cells measured. Groups were compared 
through Wilcoxon signed-ranked test with * p<0.05. 
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with Y1R antagonism
[99]. Therefore, an abrogation of the inhibitory signalling of Y1R by 
BIBP3226 antagonism might be responsible for the observed TRAP staining and morphological 
analysis results.  
  
2.2 The effect of Y1R antagonist stimulation in OC resorption activity 
 
To assess if an Y1R antagonist treatment of WT OCs would yield similar results to those 
verified in Y1R KO cells, primary bone marrow flushed cells from WT mice were seeded directly 
on top of dentine substrates on 96-well plates and were cultured for 21 days under M-CSF and 
RANKL stimulation. Moreover, soluble BIBP3226 was added to culture at a final concentration 
of 60nM and 1000nM. Untreated cells were used as control. Back-scattered electron SEM 
images revealed resorption at a lesser extent than the control dentine discs in both conditions, 
although the 1000nM BIBP3226 treated resorption pits seem to be deeper than those of 60nM 
BIBP3226 treatment (Figure 20). Resorption in 60nM BIBP3226 treated dentine discs is 
apparently more distributed throughout the dentine surface but at a shallow depth, while 
1000nM BIBP3226 treated dentine discs suffered resorption within a smaller area, as can be 
seen in Figure 20B. 
EDS spectra analysis revealed identical Oxygen, Phosphate and Calcium peaks observed at the 
dentine surface and shift to a high Carbon peak at the resorption pit as in control samples.  The 
difference between phosphate and calcium peaks at the surface and in the resorption pit seem 
to be steeper in 1000nM BIBP3226 treated samples than in 60nM BIBP3226 treated samples, 
suggesting that the latter resorption pits are shallow, resembling Y1R KO OC derived resorption 
pits. However, both BIBP3226 concentrations seem to diminish the resorption capabilities of 
OC when compared to untreated controls. 
Resorption pits derived from BIBP3226 treated cells were also reconstructed using 
Matlab software, to quantify and compare the resorption pit formation behaviour of these 
cells. Measurement and 3D reconstruction of resorption pits is demonstrated in Figure 21. Pit 
reconstruction revealed a statistically significant volume decrease in either 60nM or 1000nM 
BIBP3226 resorption pits. Interestingly, there is an increasing trend in the volume of 1000nM 
BIBP3226 treated pits compared to 60nM BIBP3226 treated ones, suggesting a non-significant 
small recovery towards control levels.  
There is a statistically significant decrease in Top Section Area in both 60nM and 
1000nM BIBP3226 treatments when compared to control resorption pits, while no significant  
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A B C 
D 
Figure 20 - SEM analysis and EDS spectra of dentine discs after culture with BIBP3226 treated OC. Bone 
marrow derived pre-OC were seeded directly on dentine discs and stimulated with M-CSF and RANKL for 21 days in 
the presence of 60nM and 1000nM BIBP3226. Representative SEM images of (A) 0nM, (B) 60nM and (C) 1000nM 
BIBP3226 treated dentine discs were taken after 21 da ys of culture with 500x and 2000x magnification. Images were 
obtained through the collection of back-scattered electrons. (D) 0nM, (E) 60nM and (F) 1000nM BIBP3226 treated 
dentine disc EDS spectra where dentine surface (Z1-red) and pit surface (Z2-green) are compared. 
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differences were observed between both treatments. Regarding Depth, however, there is only 
a statistically significant decrease in depth on 60nM BIBP3226 treated wells compared to 
control pits. Surprisingly, no significant differences were observed between 1000nM BIBP3226 
and control resorption pits, with only a decreasing trend in 1000nM BIBP3226 treated pits. 
There is a significant recovery towards control values in 1000nM BIBP3226 compared to 60nM 
BIBP3226, suggesting that the vertical resorption capacity of 1000nM BIBP3226 treated OCs is 
slightly improved. Thus, an increase in collagen degradation is possibly the mechanism of 
vertical resorption recovery. 
Similarly to Y1R KO resorption pits, the plot of Top Section Area vs Depth revealed a shift 
E F 
      A         B         C 
 
 
 
 D      E       F 
 
 
 
 
F         G           H    
  
Figure 21 - Y1R KO resorption pit 3D reconstruction. Bone marrow derived pre-OC were seeded directly on dentine discs and 
stimulated with M-CSF and RANKL for 21 days in the presence of 60nM and 1000nM BIBP3226. Dentine discs were stained with calcein 
and observed at the Confocal Microscope under 488nm radiation. Representative reconstruction of (A) 0nM, (B) 60nM and (C) 100 0nM 
BIBP3226 treated resorption pits. 3D reconstruction was performed with Matlab software using the stacked images obtained at the 
microscope with a 40x objective. Images had a resolution of 1024x1024 pixels and a z-step of 0,2849 µm. (D) Resorption pit Volume,  (E) 
Top section area and (F) Depth. Results are expressed as mean ± SEM from N (0nM; 60nM; 1000nM) = 2; 2; 3 independent experimen ts. 
n = 13 resorption pits were used from each mouse. Groups were compared through Kruskal-Wallis test and Mann-Whitney test with * 
p<0.05 (F) Scatter plot of resorption pit Top Section Area against Depth and (G) Depth and (H) Aspect Ratio against resorption pit 
Volume. 
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to the bottom of the graph and therefore there seems to be a more substantial impairment in 
lateral resorption than vertical resorption. A similar distribution can be observed in a Depth vs 
Volume plot, where an increase in depth does not lead to a proportional increase in volume in 
60nM BIBP3226 samples. However, 1000nM BIBP3226 values are more evenly distributed and 
in an approximate manner to the control samples, consistent with the Depth quantification in 
Figure 21F. 
Aspect Ratio analysis revealed that 60nM and 1000nM BIBP3226 treated pits might be 
formed in a preferential direction. These pits have an Aspect Ratio somewhat different from 
the value 1, as can be seen by analysing the distance between each dot and the black line. This 
suggests an elliptical configuration of the 60nM and 1000nM BIBP3226 treated resorption pits, 
slightly different from control resorption pits. Similarly to Y1R KO resorption pits, BIBP3226 
treated OC might have a different actin ring organization which could lead to diffe rent 
resorption pit appearance. 
An increase in Osteoclastogenesis followed by a decrease in the volume and depth of 
resorption pits after incubation with 25-dihydroxyvitamin-D3 was previously reported in 
tumour OC-like cells[100]. These results are similar to those observed after BIBP3226 incubation, 
although the extent of resorption impairment is much higher in BIBP3226 treatment.  
In conclusion, Y1R antagonism leads to impaired resorption, which is more apparent in 
60nM BIBP3226 treated OC than in 1000nM BIBP3226 treated OC.  
2.3 The effect of Y1R antagonist treatment on OC Gene Expression 
 
Y1R antagonism during Osteoclastogenesis and bone resorption yielded similar results to 
those obtained in Y1R KO experiments, yet the genetic background and cell signalling pathways 
behind them could be distinct. To assess the effect of Y1R antagonism on gene expression, the 
expression of the OC specific genes and fusion involved genes was studied. Primary bone 
marrow flushed cells were seeded on 24-well plates under M-CSF and RANKL stimulation for 
14 days, in the presence of 60nM and 1000nM BIBP3226. mRNA was extracted at day 7 and 
day 14 time points, following cDNA synthesis and amplification. 
Differentiation Markers 
The analysis of OC specific markers of differentiation in BIBP3226 treated cultures 
revealed an increasing trend in the TRAP expression in 60nM BIBP3226 treated cells and a 
statistically significant increase in early stages of differentiation of 1000nM BIBP3226 treated 
cells (Figure 22). Interestingly, TRAP expression followed an increasing trend from 60nM to 
1000nM BIBP3226 treatment, suggesting that OC behave differently with different 
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concentrations of Y1R antagonists. However, at day 14 of differentiation, TRAP levels were 
similar in the different conditions. These results seem contradictory with the previous 
resorption assays, since an increase in TRAP expression could lead to augmented resorption 
capacity. Nevertheless, it could explain the slight recovery in vertical resorption observed in 
1000nM BIBP3226 treated resorption pits, where the resorption impairment verified in these 
cells could be caused by other factors yet unknown. 
CTR expression was increased in BIBP3226 treated cells in early stages of differentiation, 
although ANOVA analysis did not show any statistical significance.  OSCAR was slightly 
upregulated at day 7 in both BIBP3226 treatments, although it was not statistically significant.  
Strikingly, CATK levels were the same as control mRNA levels, with a slight increasing 
trend at day 14 in 60nM BIBP3226 treated cells. Similarly to TRAP expression, these results are 
quite unexpected since resorption assays were comparable to the Y1R KO genotype, where 
CATK downregulation seems to be one of the causing factors. Y1R antagonism must therefore 
cause resorption impairment through different signalling pathways than the ones prompted by 
the absence of Y1R. 
  A       B 
 
 
 
 
 
  C       D 
Figure 22 - Expression of OC differentiation markers in BIBP3226 treated OC. Maturation of bone marrow derived 
pre-OC was induced with M-CSF and RANKL for 14 days in 24-well culture plates in the presence of 60nM and 1000nM 
BIBP3226. mRNA was collected at the given time points from 3 replicates. (A) TRAP, (B) CTR, (C) OSCAR and (D) CATK gene 
expression quantification relative to GADPH constitutive expression. Results are expressed as mean ± SEM from 3 
independent experiments. Groups were compared through ANOVA and independent-samples t-test with * p<0.05. 
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OC differentiation markers were only increased in earlier stages of differentiation after 
BIBP3226 treatment, with the exception of CATK. At day 14 no differences were observed in 
every OC marker tested. Thus, the increase in OC differentiation resulting from BIBP3226 
treatment previously demonstrated by TRAP+ MNC counting cannot be explained by increased 
expression of OC differentiation markers. Yet, as mRNA levels do not always reflect the protein 
levels, this increase in OC differentiation markers at day 7 may not reflect the actual protein  
synthesis, which could be confirmed by ELISA in future studies.  
Fusion Proteins 
Pre-OC fusion gene expression has shown no differences in all genes analysed (Figure 
23). However, there is a slight increase in CD47 expression in BIBP3226 treated cells when 
compared to control levels. Thus, the slightly increased OC area and TRAP+ MNC numbers 
   A       B 
 
 
 
 
      
   C       D 
 
 
 
 
       E 
Figure 23 - Expression of pre-OC fusion genes in BIBP3226 treated cells. Maturation of bone marrow derived pre-
OC was induced with M-CSF and RANKL for 14 days in 24-well culture plates in the presence of 60nM and 1000nM 
BIBP3226. mRNA was collected at the given time points from 3 replicates. (A) DC-STAMP, (B) Atp6v0d2, (C) CD9, (D) CD47 
and (E) MCP1 gene expression quantification relative to GADPH constitutive expression. Results are expressed as mean ± 
SEM from 3 independent experiments. Groups were compared through paired t-test with * p<0.05. 
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observed in BIBP3226 treated cells might be due to an increase in CD47 expression at the 
cellular membrane, in contrast of what was verified in Y1R KO OCs. Once again, it seems that 
the regulatory pathways leading to the same results are different whether Y1R is absent or it 
suffers antagonist stimulation. Regarding pre-OC fusion, Y1R antagonist treatment could lead 
to an upregulation of CD47 instead of the MCP1 increased expression observed in Y1R KO 
samples. Nevertheless, the number of samples should be increased in future studies to 
confirm these results and to reduce the associated error to these measures.  
Upon NPY stimulation, Y1R is rapidly internalized through a clathrin-dependent 
endocytic pathway as part of a desensitization process, as Gicquiaux and co-workers 
demonstrated using endocytic inhibitors. Y1R agonist internalization is also partially dependent 
on G protein activation, since internalization was reduced after treatment with G protein 
inhibitor pertussis toxin[99]. However, antagonist receptor internalization was not affected by 
pertussis toxin treatment and it has shown reduced sensitivity to endocytic inhibitors, 
although its internalization was still significantly reduced after endocytic inhibition [97]. 
Furthermore, Y1R is recycled back to the cellular membrane after internalization contrarily to 
what occurs after antagonist binding. Antagonist Y1R internalization led to a non-recoverable 
loss of 50% of total binding sites at the cellular surface [97], which point to a marked difference 
between agonist and antagonist binding and internalization. Therefore, antagonist stimulation 
of Y1R could lead to different signalling pathways besides inhibition of the normal cellular 
response to NPY, which could explain the different mRNA expression observed in BIBP3226 
treated and Y1R KO cells. 
In addition, in CHO-K1 cells BIBP3226 was reported to cause an increase in cAMP and 
Ca2+ cellular levels, as well as Phospholipase C (PLC) activation, when present at concentrations 
higher than 1µM[101, 102]. The presence of G protein inhibitors did not prevent these cellular 
responses, which point to an Y1R independent effect. However, this seems to be a cell-type 
dependent response, since no calcium elevation was observed after BIBP3226 incubation in 
SK-N-MC cells. Nonetheless, a receptor-independent BIBP3226 response in OC such as 
diffusion through the cellular membrane and intracellular signalling should not be ruled out in 
the analysis of the previous differentiation, resorption and mRNA expression results  and 
testing the specificity of the antagonist signalling should be a priority in future studies.  
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3 - Osteoclastogenesis on an OB/OC co-culture model 
 
As bone remodelling occurs in a highly regulated manner with a close interaction 
between different cells, a co-culture model could replicate in an approximate way the myriad 
of signalling processes that takes place between the main cell types of the bone, OBs and OCs. 
Furthermore, it would be of interest to study the Y1R pathway in this interaction since the 
influence of OB on osteoclastogenesis in an Y1R deletion model is still poorly understood. 
 
3.1 – Osteoclastogenesis on an Y1R KO OB/OC co-culture model 
 
 A direct co-culture model using calvarial OB and primary bone marrow flushed cells was 
established in order to allow direct coupling and integrin signalling between OB and OC. OB 
adhesion, growth and expression of OC differentiation cytokines was stimulated by 
dexamethasone, ascorbic acid, β-glycerophosphate, PGE2 and VitD3 for 1 day before the direct 
seeding of M-CSF stimulated pre-OC. Co-culture was maintained for 21 days under PGE2 and 
VitD3 stimulation. TRAP expression was assessed at day 7 and 14, genetic expression  of OBs 
and OCs was analysed at day 1 and 14 and late calcium deposition was assessed at day 21.  
TRAP staining results are presented in Figure 24. No statistically significant differences were 
found between Y1R KO and WT TRAP+ MNC numbers. Microscopic analysis show differentiated 
OCs in both conditions at day 7 time point, although WT OCs are larger at this early stage. At 
day 14, differentiated OC are present in similar number and size in both conditions. 
Unfortunately, OBs seem to stain with a light pink colour and the high cellular density hampers 
the TRAP+ MNC counting, which could result in an error-prone evaluation. In fact, TRAP 
expression and internalization by OB was previously reported [103]. In addition, TRAP+ MNC 
counting was performed in an inverted microscope, thus the OBs in the bottom of the well 
were visualized on top of the OC. Furthermore, at day 14 loose OB matrix can be observed 
which could mean that some of the cells present on top were released and discarded in 
medium changes. OB-produced collagenous matrix is clearly visible over the differentiated OC 
at later stages of differentiation and this matrix seems to lose adhesion capacity because, 
instead of being spread throughout the entirety of the well as observed in OB monocultures 
(data not shown), it is retracted and only partial ly adhered. This could be due to the release of 
resorption enzymes by mature OC which would degrade the collagenous matrix.  
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Compared to OC monocultures, OCs co-cultured with OBs apparently differentiate faster 
with an increased size, because cell size at day 7 seems comparable to OC monoculture cells at 
day 14. No marked differences were observed between Y1R KO and WT OC when in co-culture, 
suggesting that the absence of Y1R signalling in OC was partially countered by OB stimulus. 
Further experiments should be conducted to confirm these results, since only two 
independent experiments were performed. A different counting method should also be 
employed to reduce errors. 
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Figure 24 – TRAP Staining of Y1R KO co-cultures. Bone marrow flushed pre-OC were seeded directly on top of calvarial OB 
and cultured for 14 days with 1000nM PGE2 and 10nM VitD3. Representative images of (A) WT and (B) Y1R KO co-cultures at (1) day 
7 and (2) day 14 time points are presented. Whole well images are shown on the left and images taken with the microscope with a 
10x objective are shown on the right. Scale bar, 100µm. (C) Number of TRAP
+
 MNCs. TRAP
+
 OC with more than 3 nuclei were 
counted. Results are expressed as mean ± SEM from 2 independent experiments. Groups were compared through ANOVA and 
independent-samples t-test with * p<0.05. 
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A         B 
 
 
 
 
 
C            D 
 
 
 
 
 
            E 
Figure 25 – Expression of OC-specific differentiation markers in Y1R KO co-cultures. Bone marrow flushed pre-OC were 
seeded directly on top of calvarial OB and cultured for 14 days with 1000nM PGE2 and 10nM VitD3. mRNA was collected at the 
given time points from 3 replicates. (A) TRAP, (B) CTR, (C) OSCAR, (D) CATK, and (E) RANK gene expression quantification relative to 
GADPH constitutive expression. Results are expressed as mean ± SEM from 3 independent experiments. Groups were compared 
through ANOVA and independent-samples t-test with * p<0.05. 
OC Differentiation Markers 
OB and OC specific gene expression was also analysed, with focus on genes involved in 
Osteoclastogenesis. Y1R KO co-cultures have shown a general increase in OC specific 
differentiation marker expression at day 14 time point, with exception of CATK  (Figure 25). 
Expression of TRAP, CTR, OSCAR and CATK genes at day 1 was negligible, no differentiation 
occurred at this early stage as expected. At day 14, TRAP expression revealed a non-significant 
increasing trend in Y1R KO co-culture while OSCAR expression was significantly upregulated. 
CTR expression apparently increased in Y1R KO co-culture but the high associated error did not 
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allow any definite conclusion. CATK expression showed no significant differences but given the 
increase in the other OC differentiation markers and the expression decrease observe d in Y1R 
KO OC monoculture, this result is not unexpected. Interestingly, RANK expression revealed a 
decreasing trend at day 1 time point in Y1R KO co-culture, with a non-significant increase at 
day 14. This could explain the increase in size of WT OC at day 7 compared to Y1R KO OC 
observed in the TRAP staining, since RANK signalling might be decreased.  
OB Specific Genes Involved in Osteoclastogenesis 
Contrarily to the results obtained from OC monocultures, OC-specific differentiation 
markers were generally upregulated, which could point to a stimulatory effect of OB when Y1R 
signalling is absent. To further explore this possibility, RANKL and OPG expression by OBs  was 
analysed. Interestingly, RANKL expression by Y1R KO OBs was non-significantly decreased in 
comparison to WT values at day 1 (Figure 26). However, at day 14, RANKL expression had a 
statistically significant 4-fold increase compared to WT expression.  
OPG levels were constant in WT cells throughout the 14 days of co-culture. Y1R KO OBs 
had a decreasing trend in OPG expression compared to WT OBs, but at day 14 expression of 
R A N K L
m
R
N
A
 E
x
p
r
e
s
s
io
n
 l
e
v
e
ls
D
1
D
1
4
0 .0 0 0
0 .0 0 2
0 .0 0 4
0 .0 0 6 W T  O B  /
W T  O C
Y 1 R  K O  O B  /
Y 1 R  K O  O C
*
p = 0 .0 8 4
O P G
m
R
N
A
 E
x
p
r
e
s
s
io
n
 l
e
v
e
ls
D
1
D
1
4
0 .0 0 0 0
0 .0 0 0 2
0 .0 0 0 4
0 .0 0 0 6
0 .0 0 0 8 W T  O B  /
W T  O C
Y 1 R  K O  O B  /
Y 1 R  K O  O C
p = 0 .0 9 3
R A N K L /O P G  E x p re s s io n  R a tio
R
a
ti
o
D
1
D
1
4
0
5
1 0
1 5 W T  O B  /
W T  O C
Y 1 R  K O  O B  /
Y 1 R  K O  O C
p = 0 .0 5
p = 0 .0 5
A            B 
 
 
 
 
 
        C 
Figure 26 – Expression of OB-specific RANKL and OPG genes in Y1R KO co-cultures. Bone marrow flushed pre-OC were 
seeded directly on top of calvarial OB and cultured for 14 days with 1000nM PGE2 and 10nM VitD3. mRNA was collected at the 
given time points from 3 replicates. (A) RANKL and (B) OPG gene expression quantification relative to GADPH constitutive 
expression. Results are expressed as mean ± SEM from 3 independent experiments. Groups were compared through ANOVA 
and independent-samples t-test with * p<0.05. (C) RANKL/OPG expression ratio. Groups were compared through Kruskal -
Wallis test and Mann-Whitney U-test with * p<0.05. 
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Figure 27 – Calcium deposition quantification by Alizarin Red 
staining in Y1R KO co-cultures. Bone marrow flushed pre-OC were 
seeded directly on top of calvarial OB and cultured for 21 days with 
1000nM PGE2 and 10nM VitD3. Representative images of (A) WT and 
(B) Y1R KO OB calcified matrix staining with Alizarin Red. (C) 
Quantification of the calcium-associated Alizarin Red. Results are 
expressed as mean ± SEM from N (WT; Y1R KO) = 2; 1 independent 
experiments. 
OPG was similar to control levels. As OPG sequestrates RANKL and inhibits osteoclastogenesis, 
RANKL/OPG ratio was calculated and compared. RANKL/OPG ratio was increased at every time 
point studied. This is consistent with the findings of Teixeira and co-workers that NPY inhibits 
RANKL expression and stimulates OPG release from OBs [54]. Therefore, RANKL mRNA increase 
and OPG mRNA decrease is expected in Y1R KO OBs due to the absence of Y1R signalling. 
This increased RANKL/OPG ratio is probably responsible for the general increase in OC-
specific differentiation marker expression. Since RANKL expression is higher in Y 1R KO co-
cultures, an increase in osteoclastogenesis and differentiation marker expression is expected 
compared to WT co-cultures. However, these results are not consistent with the TRAP staining 
assays performed previously, since no increase in TRAP+ MNCs were observed. TRAP staining 
assays should be repeated in the future to clarify if an increase in TRAP + MNCs is verified or if 
there is some inhibitory factor in Y1R KO cultures. 
To study the influence of Y1R signalling in OB driven matrix mineralization on the co-
culture model, calcium deposition was quantified by Alizarin Red staining at later stages of 
culture. Alizarin Red stains free and 
mineralized calcium and it is widely 
used to determine the presence of 
calcium deposits by OBs. Alizarin Red 
staining did not reveal significant 
differences between Y1R KO and 
control samples (Figure 27). An 
increase in mineralization would be 
expected since Y1R signalling was 
previously shown to inhibit mineral 
deposition in vitro and in vivo[54, 57]. 
These are preliminary results 
since few experiments were 
conducted in order to obtain reliable 
data. Van Kossa Staining could 
alternatively be used to detect 
phosphate deposits and complement 
this analysis. 
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3.2 The effect of Y1R antagonism on Osteoclastogenesis in an OB/OC co-culture model 
 
In order to study the influence of Y1R antagonism in Osteoclastogenesis in an OB/OC co-
culture model. OB adhesion, growth and expression of OC differentiation cytokines was 
stimulated by dexamethasone, ascorbic acid, β-glycerophosphate, PGE2 and VitD3 for 1 day 
before the direct seeding of M-CSF stimulated pre-OC. Co-culture was maintained for 21 days 
under PGE2 and VitD3 stimulation, with the presence of 60nM and 1000nM BIBP3226. TRAP 
expression was assessed at day 7 and 14, genetic expression of OBs and OCs was analysed at 
day 1 and 14 (Day 1 without BIBP3226) and late calcium deposition was assessed at day 21. 
TRAP staining revealed no differences in TRAP+ MNC number at day 7 time point (Figure 
28). Microscopic images show OC present in similar number and size in both treatments 
compared to control samples. At day 14 there is a slight decreasing trend in TRAP + MNCs in 
60nM BIBP3226 treated OCs compared to control OCs. No differences were observed in TRAP + 
MNCs between 1000nM BIBP3226 treated OCs and control cells. Once again, co-cultured OC 
do not show the same behaviour as OC in monoculture, no increase in TRAP + MNCs is observed 
contrarily to the increase observed in monocultures. Further experiments should be conducted 
to decrease errors and strengthen the observed results, yet there seems to be an inhibitory 
stimulus when Y1R is antagonized. It is generally accepted that Y1R signalling inhibits osteoblast 
growth and RANKL production; thus Y1R antagonism should stimulate osteoclastogenesis. 
Therefore, this co-culture model should be further optimized in future studies.  
OC Differentiation Markers 
In addition, the expression of OC specific differentiation markers was studied. Results 
were very similar to those observed in Y1R KO co-cultures, with a generalized increase in OC 
marker expression in both BIBP3226 treatments with the exception of CATK (Figure 29). Since 
it was expected that no differences would be observed in such a short time, no BIBP3226 was 
added to the day 1 wells to avoid wasting resources. Expression of TRAP, CTR, OSCAR and CATK 
genes at day 1 was negligible, no differentiation occurred at this early stage as expected. TRAP 
expression was significantly increased in 60nM BIBP3226 treated OCs and an increasing tre nd 
was observed in 1000nM BIBP3226 treated OCs compared to control cells. CTR and OSCAR had 
very similar expression profiles, with a non-significant increasing trend in 1000nM BIBP3226 
treated cells. Expression of these genes was also increased in 60nM BIBP3226 treated OCs, but 
no conclusions were made due to the high associated error. CATK expression showed no 
differences in BIBP3226 treated cells compared to the controls.  
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B1 
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D 
A1 A2 
Figure 28 - TRAP Staining of BIBP3226 treated co-cultures.  Bone marrow flushed pre-OC were seeded directly on top of calvarial 
OB and cultured for 14 days with 1000nM PGE2 and 10nM VitD3 in the presence of 60nM and 1000nM BIBP3226. Representative images 
of (A) 0nM, (B) 60nM and (C) 1000nM BIBP3226 treated co-cultures at (1) day 7 and (2) day 14 time points are presented. Whole well 
images are shown on the left and images taken with the microscope with a 10x objective are shown on the right. Scale bar, 100µm. (D) 
Number of TRAP
+
 MNCs. TRAP
+
 OC with more than 3 nuclei were counted. Results are expressed as mean ± SEM from 2 independent 
experiments. Groups were compared through ANOVA and independent-samples t-test with * p<0.05. 
T
R
A
P
+
 M
N
C
s
D
7
D
1
4
0
5 0
1 0 0
1 5 0
0nM
6 0nM
1 0 0 0 n M
p = 0 .0 5 2
B IB P 3 2 2 6
C o n c e n tra tio n
 
     56 
 
OB Specific Genes Involved in Osteoclastogenesis 
RANKL and OPG expression was also analysed. Interestingly, only 1000nM BIBP3226 
treated OBs had a statistically significant increase in RANKL expression, 60nM BIBP3226 
treated OBs RANKL expression was similar to the controls (Figure 30). OPG expression was 
similar in every condition, with no statistically significant differences observed. Thus, the 
increased RANKL expression in 1000nM BIBP3226 led to an increased RANKL/OPG ratio. This 
increasing trend was not statistically significant (p=0.05) probably due to the non-parametrical 
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Figure 29 – Expression of OC-specific differentiation markers in BIBP3226 treated co-cultures. Bone marrow 
flushed pre-OC were seeded directly on top of calvarial OB and cultured for 14 days with 1000nM PGE2 and 10nM VitD 3 
in the presence of 60nM and 1000nM BIBP3226. mRNA was collected at the given time points from 3 replicates.  (A) TRAP, 
(B) CTR, (C) OSCAR, (D) CATK, and (E) RANK gene expression quantification relative to GADPH constitutive expression. 
Results are expressed as mean ± SEM from 3 independent experiments. Groups were compared through ANOVA and 
independent-samples t-test with * p<0.05. 
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statistical test used. RANKL/OPG ratio of 60nM BIBP3226 treated OBs was similar to control 
levels. 
These results were not consistent with the TRAP staining previously performed. 
Considering the genetic expression profile observed, it was expected that 1000nM BIBP3226 
treated cells would have increased TRAP+ MNC numbers. In order to verify these results, 
further experiments should be conducted to produce statistically solid results.  
Since RANKL expression is elevated in Y1R KO and BIBP3226 treated co-cultures, an 
inhibiting factor should be counteracting the RANKL stimulation, resulting in similar control 
and treated TRAP+ MNCs. Nitrous Oxide was shown to inhibit Osteoclastogenesis in previous 
studies after stimulation by Interferon gamma and Fibronectin [104, 105]. Interleukins (IL) are 
cytokines involved in the regulation of inflammation and i mmune response but they also 
modulate bone resorption, such as the osteoclastogenesis inhibitor IL-4[106, 107] or the 
osteoclastogenic IL-1[108] and IL-11[109]. IL-33 and IL-18 were reported to be produced by OB and 
A B 
C 
Figure 30 - Expression of OB-specific RANKL and OPG genes in BIBP3226 treated co-cultures. Bone marrow flushed 
pre-OC were seeded directly on top of calvarial OB and cultured for 14 days with 1000nM PGE2 and 10nM VitD3 in the 
presence of 60nM and 1000nM BIBP3226. mRNA was collected at the given time points from 3 replicates. (A) RANKL and 
(B) OPG gene expression quantification relative to GADPH constitutive expression. Results are expressed as mean ± SEM 
from 3 independent experiments. Groups were compared through ANOVA and independent-samples t-test with * p<0.05. 
(C) RANKL/OPG expression ratio. Groups were compared through Kruskal -Wallis test and Mann-Whitney U-test with * 
p<0.05. 
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to inhibit osteoclastogenesis[110, 111]. In future studies the influence of these inhibitory factors 
should be investigated if the TRAP staining results are confirmed.  
Calcium deposition in BIBP3226 treated co-cultures was assessed through Alizarin Red 
Staining (Figure 31). No statistically significant differences between calcium deposition in 
60nM and 1000nM BIBP3226 treated co-cultures compared to control deposition. However, 
conflicting results were obtained in the two independent experiments performed, where in 
one of the experiments Alizarin Red was slightly decreased in BIBP3226 treated co-cultures 
and in the other it was slightly increased. Further optimization should be done in order to 
clarify these results. Performing the Alizarin Red staining in larger wells and increasing  the 
number of replicates should improve measurement quality.  
In conclusion, there seem to be no differences in TRAP+ MNC formation between either 
Y1R KO or BIBP3226 treated co-cultures and WT controls, in spite of the genetic expression 
profile of OBs and OCs. No differences in matrix mineralization were observed in Y1R KO co-
cultures and after BIBP3226 treatment. More experiments as well as further optimization  are 
required to clarify these results.  
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Figure 31 - Calcium deposition quantification by Alizarin Red staining in BIBP3226 
treated co-cultures. Bone marrow flushed pre-OC were seeded directly on top of calvarial 
OB and cultured for 21 days with 1000nM PGE2 and 10nM VitD3 in the presence of 60nM 
and 1000nM BIBP3226. Representative images of (A) 0nM, (B) 60nM and (C) 1000nM 
BIBP3226 treated OB-calcified matrix staining with Alizarin Red. (D) Quantification of the 
calcium-associated Alizarin Red. Results are expressed as mean ± SEM from 2 
independent experiments with * p<0.05. 
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Concluding remarks and perspectives 
 
1. An upregulated osteoclastogenesis was observed in bone marrow derived pre-
OC from Y1R KO mice, with increased TRAP
+ MNC numbers and OC section area and increased 
MCP1 expression, consistent with an augmented pre-OC fusion. However, Y1R KO OC exhibited 
impaired bone resorption capacity, with decreased TRAP and CATK expression. Thus, Y1R 
absence led to significant changes in OC behaviour, probably due to changes in RANK/RANKL 
signalling or a stimulation of previously inhibited secondary messengers.  Future studies are 
proposed on the assessment of the role of MMPs in the decreased resorption capacity of Y1R 
KO OCs and the study of other fusion regulatory proteins such as ADAM8, MFR and TREM2. In 
addition, OC resorption assays in dentine slices should be repeated to strengthen the obtained 
results in the pit 3D reconstruction.  
2. Secondly, BIBP3226 treated cells revealed an increase in osteoclastogenesis, 
with higher number of TRAP+ MNCs but no differences were observed in regards to OC section 
area. OC differentiation marker expression was upregulated after BIBP3226 treatment. 
Resorption capacity of BIBP3226 treated cells also demonstrated a significant decrease in pit 
volume and top section area. In addition, future studies with GPCR inhibitors should be 
conducted to verify if the observed results are Y1R dependent. The same questions are posed 
regarding other OC fusion and resorption proteins as in Y1R KO cells. 
3. Finally, an OB/OC co-culture model was established, with successful 
osteoclastogenesis in all conditions. However, no changes were observed in TRAP+ MNC 
numbers. Genetic expression analysis revealed an increase in OC specific differentiation 
markers in Y1R KO co-cultures. This increase in OC marker expression was probably due to a 
significant increase in RANKL production by Y1R KO OBs. However, this genetic expression 
analysis was not consistent with TRAP staining results. This could point to the presence of an 
OB secreted OC inhibitor upregulated upon Y1R deletion. BIBP3226 treatment yielded the 
same results as the ones obtained after Y1R gene deletion but in a smaller extent, with 
increased OC marker expression and no differences in TRAP + MNCs and mineralization. In 
future studies, it would be interesting to establish WT OB/Y1R KO OC and Y1R KO OB/WT OC 
co-cultures in order to perceive which cell  type could have the most influence on 
osteoclastogenesis after Y1R deletion. The influence of OC on bone formation should also be 
analysed through Alizarin Red, Van Kossa and ALP activity assays, but in larger wells and with 
more replicates to generate reliable data. 
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In summary, the present work contributes for the unravelling of the role of Y1R signalling 
on OC behaviour while exploring the effect of BIBP3226. In addition, the first steps were taken 
towards the establishment of a co-culture model that could approximate an in vitro setting to 
in vivo conditions. 
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Annex 
 
 
Figure 32 – Dentine disc SEM images. (A) Control samples without seeded cells at 500x and 
2000x magnification. (B) Resorption pit at 20000x magnification. Collagen fibres are clearly visible.  
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